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Summary 
Aeromonas species are Gram-negative facultative anaerobic bacteria which are 
widespread in fresh water and salt water. Aeromonas caviae and Aeromonas 
hydrophila are two kinds of mesophilic aeromonads which belong to genus 
Aeromonas and are emerging as major pathogens in humans. Flagella are important 
pathogenic factors of bacteria and there are two kinds of flagella discovered in A. 
caviae and A. hydrophila which are polar flagella and lateral flagella (Rabaan et al. 
2001; Tabei et al. 2009; Canals et al. 2006a).  
 
The flagella of Aeromonas are glycosylated and investigation of glycosylation in 
flagellin biosynthesis is valuable for the understanding of pathogenicity of Aeromonas 
species. The aim of this project is to investigate the glycosylation during flagellin 
biosynthesis in A. caviae. It has been discovered that the flagella of A. caviae are 
glycosylated 6 to 8 times by Pse5Ac7Ac which is under the control of Maf1 which is 
known as flagellin glycosyl-transferase (Parker et al. 2012). Theoretically, Maf1 of A. 
caviae Sch3N has the ability to transfer activated pseudaminic acid (CMP-Pse5Ac7Ac) 
to the hydroxyl group of serine and threonine residues in the central immunogenic 
D2/D3 domain of flagellin of A. caviae Sch3N (Parker et al. 2012; Tabei et al. 2009). 
The details of how Maf1 interacts with flagellin will be explored in this project. 
 
CMP-Pse5Ac7Ac which is the substrate for glycosylation is generated from 
UDP-GlcNAc. The biosynthesis of CMP-Pse5Ac7Ac is under the control of flm locus 
including flmA, flmB, neuA, neuB, flmD. The pseudaminic acid biosynthetic pathway 
has been confirmed in Campylobacter jejuni and related enzymes are homologous 
proteins of A. caviae (Schoenhofen et al. 2006). The proteins encoded by the flm 
genes will be applied in this project to investigate the biosynthesis of 
CMP-Pse5Ac7Ac. In addition, there is evidence that the LPS O-antigen incorporates 
with Pse5Ac7Ac. The substrate of O-antigen glycosylation is also CMP-Pse5Ac7Ac 
(Tomás 2012). The connections between glycosylation in LPS O-antigen biosynthesis 
and flagellin biosynthesis will be investigated in this project. 
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Chapter 1 Introduction 
1.1 Aeromonas species 
Aeromonas species are Gram-negative facultative anaerobic bacteria which are 
widespread in fresh and salt water. The genus Aeromonas belong to the family of 
Aeromonadaceae. Furthermore，this family also includes the genera Oceanimonas 
and Tolumonas (Martin-Carnahan and Joseph 2005). 
 
The understanding of members of the genus Aeromonas has been developing for 
many decades. In 1980, there were only four Aeromonas species known (Aeromonas 
hydrophila, Aeromonas punctata, Aeromonas salmonicida, and Aeromonas sobria). 
As new species have been described, there are now 24 species of Aeromonas that 
are accepted nowadays (Janda and Abbott 2010). At the very beginning, the genus 
Aeromonas were considered as pathogens causing systemic illnesses in 
poikilothermic animals, but it is acknowledged today that the genus Aeromonas is not 
only responsible for diseases in cold-blooded species but also responsible for various 
infectious complications in both the immunocompetent and immunocompromised 
person (Janda and Abbott 2010). It has been discovered that the genus Aeromonas 
can cause primary and secondary septicemia in immunocompromised persons, 
serious wound infections in healthy individuals and other diseases including peritonitis, 
meningitis, infections of the joints, bones and eyes and even gastroenteritis (Janda 
and Abbott 1998). 
 
Generally the genus Aeromonas was divided into two principal subgroups based 
on optimal growth temperature and motility: the mesophilic and motile species 
including A. hydrophila, A. caviae, and A. sobria as well as psychrophilic and immotile 
species such as A. salmonicida (Krieg and Holt 1984). The mesophilic aeromonads 
are emerging as major pathogens in humans. Approximately 85% of the 
aeromonad-related diseases are caused by three mesophilic aeromonads: A. 
hydrophila, A. caviae, and A. sobria (Janda 1991).  
 
There are many pathogenic factors of Aeromonas including surface 
polysaccharides such as capsule, lipopolysaccharide (LPS), iron-binding systems, 
exotoxins, S-layers, secretion systems, extracellular enzymes, fimbriae and flagella 
(Tomás 2012). Furthermore, there are some proteins in Aeromonas species that are 
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glycosylated and glycosylation plays an important role in the survival of both 
eukaryotes and prokaryotes. 
1.1.1 Flagella and flagellins 
The prokaryote flagellum is made up of an external part which includes the 
filament and the hook, a basal body which is the internal part embedded in the cell 
membrane (Tomás 2012) (Figure 1B). The flagellar filament is formed by flagellins 
which vary from species to species and filament cap is formed at the end of filament. 
The assembly of the flagellum starts from the basal body, followed by the 
hook-associated proteins and the filament (Rabaan et al. 2001). 
 
In prokaryotic organisms, flagella are sophisticated structures that exist on the 
bacterial surface. Flagella allow bacteria to move around and approach optimal 
environment or avoid harmful factors. When contacting with the host cell, the flagella 
also play a significant role in adhesion and biofilm formation on the host cell surface. 
Hence the flagellum is recognized as important bacterial virulence factor in 
pathogenic bacteria. Such as in A. hydrophila, polar flagella are expressed for 
swimming and lateral flagella are expressed for adhesion (Gavín et al. 2002) (Figure 
1A).  
 
A. caviae and A. hydrophila are two species of mesophilic aeromonads which 
have been widely studied. It has been confirmed that there are two kinds of flagella 
discovered in Aeromonas species (Thornley et al. 1997; Shimada et al. 1985; Gavín 
et al. 2002). The flagella filament is composed of flagellin proteins. There are two 
polar flagellins (FlaA and FlaB) and two lateral flagellins (LafA1 and LafA2) expressed 
in A. caviae as well as in A. hydrophila there are two polar flagellum flagellins (FlaA 
and FlaB) and one specific lateral flagellum flagellin (LafA) expressed (Rabaan et al. 
2001; Tabei et al. 2009; Canals et al. 2006a).  
 
The structure of flagella filament from Salmonella typhimurium has been 
described and the structure of the flagellin is similar in all bacteria. Starting with the 
N-terminal chain there are four domains including D0, D1, D2 and D3, the C-terminal 
chain is back to D0 to form a coil. The D0 and D1 are basically buried inside of the 
structure of filament while the central D2 and D3 are exposed at surface. D2 and D3 
are considered to be recognized by glycosyltransferase in bacteria such as A. caviae, 
although they are not glycosylated in Salmonella (Tabei et al. 2009; Yonekura et al. 
17 
 
2003). These findings suggest that the D2 and D3 are where the flagellar 
glycosylation occurred. Recent study about A. caviae indicated that D2 and D3 can be 
recognized by Maf1 and a C-terminal chaperone-binding domain (CBD) can directly 
interact with FlaJ which is a flagellin-specific chaperone (Parker et al. 2014). 
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(A) 
 
(B) 
 
Figure 1.1 The expression of the flagella systems in A. hydrophila and 
Structure of flagellum from bacteria. 
(A) Polar flagella system is expressed when the bacteria are living in liquid conditions. 
Lateral flagella system is expressd when the bacteria are contacting the host cell.  
 
(B) A single flagellum consists of the filament, the hook and a basal body. (OM = 
Outer membrane PG = peptidoglycan layer CM = cytoplasmic membrane) 
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1.2 Glycosylation in eukaryotes and prokaryotes 
Glycosyl acceptor molecules such as immature proteins attached to a 
carbohydrate at a hydroxyl or other functional group is known as glycosylation. 
Protein glycosylation is an extensive post-translational modification that exists in 
eukaryotes and prokaryotes. 
 
Based on the studies about glycosylation so far, glycosylation can be classified 
into two pathways: N-glycosylation in which carbohydrates are covalently attached to 
the amide asparagine residues of proteins as well as O-glycosylation in which 
carbohydrates are covalently attached to serine or threonine residues instead of 
asparagine residues (Iwashkiw et al. 2013). 
 
It is acknowledged that both N-glycosylation and O-glycosylation have been 
identified in eukaryotes and prokaryotes (Iwashkiw et al. 2013). In eukaryotes, 
N-glycosylation of proteins is the most common post-translational modification (Dwek 
1996; Varki 1993). The understanding of N-linked glycosylation and O-linked 
glycosylation in prokaryotes is developing with time. In prokaryotic organisms, both 
N-linked glycosylation and O-linked glycosylation pathways have been established 
and each pathway has been widely investigated in Campylobacter jejuni. 
 
In C. jejuni, the formation of a heptasaccharide is required for N-linked 
glycosylation while O-linked glycosylation is involved in flagellum assembly (Kalynych 
et al. 2014). The glycosylation in prokaryotes will be extensively discussed here, 
especially related to flagellin glycosylation and LPS O-antigen glycosylation. 
 
1.2.1 N-linked glycosylation and O-linked 
glycosylation in prokaryotes 
Campylobacter species are Gram-negative bacilli which are responsible for most 
cases of bacterial gastroenteritis worldwide (Allos and Acheson 2001). A well-studied 
N-glycosylation pathway and O-linked flagellar glycosylation pathway have been 
established in C. jejuni. Therefore, it makes C. jejuni a good model for the 
investigation of prokaryotic glycosylation (Szymanski and Wren 2005).  
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In C. jejuni, biosynthesis of a branched heptasaccharide is involved in the 
N-linked glycosylation process which is under the control of pgl (protein glycosylation 
locus) genes. PglA, PglB, PglC, PglD, PglE, PglF, PglH, PglI and PglJ are all encoded 
by the pgl locus. Initially, UDP-N-acetyl glucosamine (GlcNAc) is sequentially 
modified by PglF, PglE and PglD and results in UDP-bacillosamine, and then it is 
attached to a lipid carrier by PglC and result in UPP-bacillosamine. Eventually, 
glucose is added by branching enzyme PglI and five N-acetylgalactosamine (GalNAc) 
moieties are linked by PglA, PglJ and PglH to form the branched heptasaccharide 
(Merino and Tomas 2014). After the heptasaccharide is produced, it is transferred to 
the periplasm by PglK which is a flippase and the heptasaccharide is coupled to the 
asparagine residue of the acceptor polypeptide by PglB. It is remarkable that, PglB of 
C. jejuni shares a similar role to STT3 in eukaryotes which bonds glycan to the 
acceptor in N-linked glycosylation (Linton et al. 2005b) (Figure 2). 
 
Furthermore, in C. jejuni there is a specific O-linked flagellar glycosylation system 
and a series of nucleotide-activated sugars including activated pseudaminic acid is 
added to the surface-exposed domains of flagellin monomers separately via an 
oligosaccharyltransferase.  
 
There is evidence that both polar and lateral flagella are glycosylated in 
prokaryotes (Merino and Tomas 2014). In C. jejuni, flagellin is glycosylated up to 19 
times before the protein is completed while the flagellin from Aeromonas is 
glycosylated 6 or 7 times (Thibault et al. 2001; Tabei et al. 2009; Wilhelms et al. 2012). 
As far as we know, the particular purposes and functions of flagellar glycosylation still 
remains unknown but Josenhans and the colleagues confirmed that un-glycosylated 
flagellin cannot be exported from cytoplasm via the flagellar type III secretion system 
(T3SS) which indicated that glycosylation could be essential for the assembly of 
flagellins (Josenhans et al. 2002).  
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Figure 1.2. Biosynthetic pathway of branched heptasaccharide in C. 
jejuni. 
UDP-N-acetyl glucosamine (GlcNAc) is modified by PglF, PglE and PglD and 
result in UDP-bacillosamine, and then it is tranfered to a lipid carrier (UPP) by PglC 
and result in UPP-bacillosamine. Eventually, glucose is added by branching enzyme 
PglI and five N-acetylgalactosamine (GalNAc) residues are all added by PglA, PglJ 
and PglH to form the branched heptasaccharide (Linton et al. 2005a). 
 
1.3 Aeromonas genetic loci of glycosylation  
In order to investigate the glycosylation in polar flagellar biosynthesis and other 
mechanisms, it is necessary to look into the relevant genetic loci including 
glycosylation genes and flagellum structural genes. The study of these genes has not 
been completely finished. 
 
Based on the previous research, flaA, flaB, flaG, flaH and flaJ (fla locus) and flmA, 
flmB, flmD neuA, neuB (flm locus) were all identified in A. caviae Sch3N and A. 
hydrophila AH-3 (Tabei et al. 2009) (Figure 1.3). Such as flm genes in A. caviae 
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including flmA, flmB, neuA, neuB, flmD and polar flagella filament genes including flaA, 
flaB, flaG, flaH and flaJ are all interesting targets of this project (Tabei et al. 2009; 
Rabaan et al. 2001). A deep investigation of the above genes can be very valuable for 
the understanding of the mechanisms of flagella system and relevant pathogenicity of 
Aeromonas species.  
 
The fla locus of A. caviae Sch3N is linked to the biosynthesis of polar flagella 
filament. This locus includes flaA, flaB, flaG, flaH and flaJ which have been listed in 
genetic order (Rabaan et al. 2001). 
 
The flaA and flaB genes of A. caviae Sch3N encode two flagellin subunits. A 
strain that lacks flaA and flaB shows no motility and further study proved that 
production of flagellins in this strain is absolutely terminated (Rabaan et al. 2001). 
Motility and adherence drop to about 50% in the strain with single mutation in flaA or 
flaB in which flagella are still expressed. This finding indicates that FlaA and FlaB 
compose flagellin with a 1:1 ratio (Rabaan et al. 2001). 
 
FlaG encoded by flaG has been shown not to be essential for polar flagellar 
biosynthesis and export. Mutation in flaG result in decreased of cell adherence while 
the motility is not affected. The mutant appears to make an elongated filament 
(Rabaan et al. 2001). 
 
FlaH encoded by flaH has been considered as a homologue of hook-associated 
proteins (HAPs) which is usually acts as flagellum cap. The function of these proteins 
is to prevent the decomposition of unpolymerized flagellin via modification of the 
terminal of flagellar filament (Parker et al. 2014). Mutation in flaH results in entire loss 
of motility and flagella and there is no production of flagellins detected (Rabaan et al. 
2001). Besides, a study shows that flaH mutant of A. caviae Sch3N can not produce 
any fully functional filament while the flagellins that synthesized in cytoplasm can still 
be exported to the outside of cell membrane (Yonekura et al. 2000). In addition, the 
glycosylation of flagellin is still functional in this mutant which indicates that the 
glycosylation of flagellin is irrelevant to the modification of filament (Parker et al. 
2014). 
 
The protein encoded by flaJ which is downstream of flaH is considered as a 
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homologue of FlaJ of Vibrio parahaemolyticus. This protein has been regarded as a 
chaperone protein that manipulates the flagellin export (Rabaan et al. 2001). Mutation 
in flaJ also results in loss of motility and flagella which is the same as mutation in flaH 
(Rabaan et al. 2001). FlaJ stabilizes the flagellin in an unfolded form which means this 
chaperone protein prevents unfolded flagellin from polymerization in the cytoplasm via 
binding to the C-terminal interactive region (Auvray et al. 2001). 
 
Recently, a flm locus of A. caviae Sch3N was identified. This locus which includes 
flm genes is consists of flmA, flmB, neuA, flmD, and neuB. The genes are arranged as 
flmA-flmB-neuA-flmD-neuB. Following the flm locus, there are lsg and lst which 
encode the LPS O-antigen flippase and transferase (Tabei et al. 2009). 
 
In A. caviae Sch3N, the flm locus is involved in both flagellin glycosylation and 
lipopolysaccharide (LPS) O-antigen (O-Ag) biosynthesis, the mutants without these 
genes lost motility, flagella, and their LPS O-antigen (Gryllos et al. 2001). The 
proposed protein encoded by flmA is the homologue of PseB (Cj1293) of C. jejuni and 
the orthologue of FlaA1 of H. pylori (Goon et al. 2003; Creuzenet et al. 2000). FlmA is 
proposed to be essential for the Pse5Ac7Ac biosynthetic pathway (Leclerc et al. 1998; 
Tabei et al. 2009) 
 
The flmB gene is involved in the assembly of flagellar filament which is the same 
role as flmA (Leclerc et al. 1998). PseC (Cj1294) of C. jejuni is the homologue of FlmB 
of A. caviae Sch3N and this protein is working as pyridoxal-dependent 
amino-transferase in general protein glycosylation system (Szymanski et al. 1999) 
 
The neuA of A. caviae Sch3N encodes a protein that shares similar amino acid 
sequence to CMP-NeuNAc synthetases (NeuA) of H. pylori and these enzymes can 
synthesis CMP-NeuNAc from N-acetylneuraminic acid (NeuNAc) and CTP (Gryllos et 
al. 2001). PseF (Cj1311) of C. jejuni has been identified as the homologue of NeuA of 
A. caviae Sch3N. In C. jejuni, PseF is CMP-sugar synthetase in the biosynthesis of 
CMP-Pse5Ac7Ac which makes NeuA of A. caviae Sch3N the crucial enzyme related 
to CMP-Pse5Ac7Ac in A. caviae Sch3N (Schirm et al. 2003).  
 
FlmD encoded by flmD is also involved in assembly of flagellar filament (Gryllos 
et al. 2001). This protein is a chimera that includes a component that has the same 
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activity as PseH (Cj1313) of C. jejuni and FlmD is considered as the homologue of 
PseG (Cj1312) and PseH (Cj1313) of C. jejuni (Tabei et al. 2009). 
 
PseI (Cj1317) of C. jejuni is the homologue of NeuB of A. caviae Sch3N and this 
kind of protein is regarded as sugar synthetase in the biosynthesis of pseudaminic 
acid (Pse5Ac7Ac) (Thibault et al. 2001; McNally et al. 2006). From previous work, one 
of three neuB-like genes discovered in C. jejuni was shown to be required for motility 
and production of flagellins (Linton et al. 2000). 
 
Based on experimental results, mutants lacking each flm gene did not present 
functional LPS O-antigen and flagella which lack the Pse5Ac7Ac in glycosylation. 
Therefore, it can be concluded that flm locus of A. caviae Sch3N is involved in 
Pse5Ac7Ac biosynthesis (Tabei et al. 2009) 
 
The fla locus and flm locus are all identified in A. caviae Sch3N and A. hydrophila 
AH-3 as well as some maf-like genes are also discovered in these strains. However, 
the glycosylation of polar flagellum in A. caviae is different from glycosylation of polar 
flagellum in A. hydrophila.  
 
Based on the recent studies, there are some other genes also involved in flagellin 
glycosylation in A. hydrophila. An enzyme able to link sugars to a lipid carrier in A. 
hydrophila was identified. WecX which is encoded by wecX is required for the 
heptasaccharide glycosylation of the polar flagellin and this enzyme is not involved in 
the modification of O34-antigen LPS. Additionally, UDP-GalNAc formation is under 
the control of an enzyme named Gne which is encoded by gne and UDP-GalNAc is 
essential for the biosynthesis of heptasaccharide (Merino et al. 2014). 
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Figure 1.3. Genetic organization of the A. caviae Sch3N and A. hydrophila 
AH-3 flagellin and flagellar glycosylation loci.  
This diagram shows the flm, fla and maf-like genes identified in A. caviae Sch3N 
and A. hydrophila AH-3 (Tabei et al. 2009; Rabaan et al. 2001; Canals et al. 2006a; 
Canals et al. 2007; Parker et al. 2012). 
 
1.4 Putative flagellin glycosyl transferase 
The investigation of flagellin glycosyl transferase has not been finished. There are 
many homologues encoded by maf family in various bacteria species. In most cases, 
the maf-like genes are essential for flagellar biosynthesis (Karlyshev et al. 2002). 
 
In C. jejuni, seven putative maf genes have been discovered. The genes 
including maf1 (Cj1318), maf2 (Cj1333), maf3 (Cj1334), maf4 (Cj1335/6), maf5 
(Cj1337), maf6 (Cj1341) and maf7 (Cj1342)  have been revealed and phase 
variation was detected in flagellar biosynthesis, but the exact functions of the proteins 
encoded by these genes still remains unknown (Karlyshev et al. 2002). However, 
based on the experiment result, maf5 is considered involved in the formation of the 
flagellum and it is hypothetical that all of these genes are involved in flagellar 
biosynthesis and phase variation (Karlyshev et al. 2002). 
 
Some maf-like genes have been identified in A. hydrophila AH-3. The maf-1 gene 
of A. hydrophila AH-3 has been proved to be related to glycosylation of polar flagellum 
filament (Canals et al. 2006b). In addition, maf-5 gene of A. hydrophila AH-3 is 
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confirmed to be only essential for lateral flagellar biosynthesis and there is evidence 
that it is not required for polar flagellar biosynthesis (Canals et al. 2006a). Additionally, 
maf-2 of A. hydrophila AH-3 is identified and it plays a role in both the glycosylation of 
polar flagella and lateral flagella (Canals et al. 2007) (Figure 1.3).  
 
In A. caviae Sch3N, the maf1 gene named by Parker et al (2012) shared 38% 
similarity to maf-1 of A. hydrophila AH-3 is considered related to polar flagella 
glycosylation. The Maf1 encoded by maf1 in A. caviae Sch3N is considered as 
transferase in the polar flagellar biosynthesis. Based on the experimental results, it is 
essential for polar flagella-mediated motility and it has been confirmed that the 
overexpression of maf1 in cell will result in the generation of overexpressed 
glycosylated flagellins which leads to the blocking of flagellum synthesis and then it 
will cause low level of cell motility. This phenomenon indicates that the expression of 
maf1 in A. caviae Sch3N is precisely controlled and a certain amount of Maf1 is 
pivotal for the optimal cell motility (Parker et al. 2012). 
 
From the previous studies, there is evidence that FlaA and FlaB of A. caviae 
Sch3N are all modified by Pse5Ac7Ac in the flagellar biosynthesis (Tabei et al. 2009). 
It has been confirmed that pseudaminic acid is irrelevant to the interaction between 
Maf1 and flagellins which indicates that Maf1 can directly interact with flagellins 
(Parker et al. 2014). The experiments confirmed that the Maf1 is not involved in 
Pse5Ac7Ac and LPS biosynthesis and it is only required for flagellin glycosylation. 
Therefore, the Maf1 is deemed as a putative flagellin pseudaminyl transferase (Parker 
et al. 2012). Theoretically, Maf1 of A. caviae Sch3N has the ability to transfer 
activated pseudaminic acid (CMP-Pse5Ac7Ac) to the hydroxyl group of serine and 
threonine residues in the central immunogenic D2/D3 domain of flagellin of A. caviae 
Sch3N (Parker et al. 2012; Tabei et al. 2009). 
 
1.5 Aeromonas flagellin glycosylation system 
1.5.1 Aeromonas polar-flagella and lateral-flagella 
From the previous investigations, it has been revealed that polar flagella systems 
and lateral flagella systems of the Aeromonas species are all correlative in adherence 
and biofilm formation in both inorganic environments and organic environments such 
as host cell surface (Kirov et al. 2004). It has been proved that lateral flagella system 
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of A. caviae and lateral flagella system of A. hydrophila are essential for swarming 
motility in solid environment (Kirov et al. 2004; Gavín et al. 2002). Furthermore, polar 
flagella system is functional when bacteria contacting with liquid environment 
including water or body fluid (Gavín et al. 2002; Rabaan et al. 2001) (Figure 1A). 
 
1.5.2 Flagellin glycosylation system in A. caviae Sch3N 
A. caviae which is a typical pathogenic mesophilic species of Aeromonas is 
drawing the attention. In this project, A. caviae Sch3N will be researched widely as the 
model organism. Pseudaminic acid (Pse5Ac7Ac) is a nine carbon sugar similar to 
sialic acid. The biosynthetic pathway of Pse5Ac7Ac in A. caviae Sch3N is based on 
the predicted functions of proteins encoded by flm genes which are the homologues 
of enzymes of C. jejuni and H. pylori (McNally et al. 2006; Schoenhofen et al. 2006). 
With the help of PseF, PseG, PseH, and PseI from H. pylori as well as PseG and 
PseH from C. jejuni which are overexpressed in Escherichia coli and purified, the 
pseudaminic acid biosynthetic pathway was reproduced (Schoenhofen et al. 2006). 
 
PseB which is a dehydratase initiates the biosynthesis of pseudaminic acid by 
catalyzing the conversion of UDP-N-acetylglucosamine (UDP-GlcNAc) to 
UDP-2-acetamido-2,6-dideoxy-b-L-arabino-hexos-4-ulose. Subsequently, the product 
is modified by PseC which is aminotransferase and 
UDP-4-amino-4,6-dideoxy-b-L-AltNAc is generated. After processing by PseH which 
is an acetyltransferase, the UDP of 
UDP-2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose is removed by PseG which is 
a glycosyltransferase and results in 2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose. 
Eventually, this monosaccharide is converted to pseudaminic acid by PseI which is a 
sugar synthetase (Schoenhofen et al. 2006; Schirm et al. 2003). PseF acts as a 
CMP-sugar synthetase in the biosynthesis of CMP-Pse5Ac7Ac (Schirm et al. 2003) 
(Figure 1.4). Activated pseudaminic acid (CMP-Pse5Ac7Ac) is ready for the 
glycosylation and it can be transferred onto flagellin by flagellin glycosyl transferase. 
 
In A. caviae Sch3N, flagellins of polar flagella are glycosylated 6 to 8 times by 
CMP-Pse5Ac7Ac which is under the control of Maf1 which is known as flagellin 
glycosyl transferase (Parker et al. 2012). In a recent study about A. caviae Sch3N, the 
interaction between FlaJ and Maf1 has been basically explained. After flagellins 
(FlaA/B) were glycosylated by activated pseudaminic acid (CMP-Pse) in a Maf1 
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dependent manner, the chaperone-binding domain (CBD) of the glycosylated flagellin 
will be recognized and bound by the flagellin-specific chaperone FlaJ (Parker et al. 
2014). Additionally，experimental results show that the affinity between FlaJ and 
glycosylated flagellin is higher than the affinity between FlaJ and un-glycosylated 
flagellin. This result is significant for the export of glycosylated flagellin (Parker et al. 
2014). Besides, it has been discovered that flagellin glycosylation is irrelevant to FlaJ 
and CBD of flagellin which are crucial for flagellin export (Parker et al. 2014). 
 
In conclusion, glycosylation and assembly of flagellins of polar flagella in A. 
caviae Sch3N can be described like this: The original flagellin synthesized from FlaA 
and FlaB has a central D2/D3 domain which can be recognized by Maf1 and a 
C-terminal chaperone-binding domain (CBD) which can directly interact with FlaJ. 
First of all, Maf1 is attached to the central D2/D3 domain of original flagellin with 
CMP-Pse5Ac7Ac and then the original flagellin is glycosylated by Pse5Ac7Ac. After 
that, Maf1 is released from glycosylated flagellin for next circulation. Secondly, as it 
was mentioned before, FlaJ is bound to the C-terminal chaperone-binding domain 
(CBD) of flagellin (FlaA /FlaB+Pse) and this complex is transported to the basal body 
of flagellum. Finally, the glycosylated flagellin is discharged from intracellular 
environment via T3SS. The exported flagellin will be polymerized by FlaH at the distal 
tip and the complete flagellar filament will be produced. Glycans can attach to the 
exposed central D2/D3 domain after the flagellin is folded (Parker et al. 2012; Parker 
et al. 2014) (Figure 1.5). Additionally, Parker et al found out that un-glycosylated 
flagellin is exported via T3SS too. This finding suggests that un-glycosylated flagellin 
can be recognized by the export apparatus of flagellar T3SS and the glycosylation of 
pseudaminic acid has no influence on the export of flagellin (Parker et al. 2014). 
However, the system appears to have a higher affinity for the glycosylated flagellin. 
 
However, there are some evidences about the glycosylation of lateral flagellum in 
A. caviae Sch3N. The glycosyl groups of the lateral flagellum was detected by 
periodate oxidation and hydrazine biotinylation in a previous study, but the 
investigation in this field is still insufficient (Gavín et al. 2002). 
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Figure 1.4. The proposed CMP-Pse5Ac7Ac biosynthetic pathway in C. 
jejuni and A. caviae. 
This diagram shows CMP-Pse5Ac7Ac is synthesized from 
UDP-N-acetylglucosamine via PseB (Cj1293), PseC (Cj1294), PseH (Cj1313), PseG 
(Cj1312), PseI (Cj1317) and PseF (Cj1311) or FlmA, FlmB, FlmD, NeuB and NeuA 
(Schoenhofen et al. 2006). 
1.5.3 Flagellin glycosylation system in A. hydrophila 
AH-3  
Recently, the glycans involved in glycosylations of flagellins of polar flagella 
(FlaA/FlaB) and flagellins of lateral flagella (LafA) have been revealed in A. hydrophila 
AH-3. The flagellins of polar flagella are glycosylated 6 times and initially glycosylated 
by a single monosaccharide which is derivative of pseudaminic acid. The flagellins of 
lateral flagella are most likely glycosylated by another phosphorylated derivative of 
pseudaminic acid (Wilhelms et al. 2012). 
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In a recent study, flagellins of polar flagellum of A. hydrophila AH-3 were 
discovered to be O-linked glycosylated with a heterogeneous glycan. A remarkable 
finding which is a lipid carrier is involved in flagellin glycosylation has not been 
reported before. The proposed polar flagellum glycosylation in A. hydrophila AH-3 is 
described: WecX links CMP-Pse-like to undecaprenylphosphate (Und-P) and then 
two hexoses are added. After that, three N-acetylhexosamines or derivates of 
N-acetylhexosamine are added and an unknown glycan of 102 Da is added at last. 
Finally, this heptasaccharide is attached to the threonine/serine amino acid residue of 
the polar flagellin by a putative OT (Merino et al. 2014). 
 
The lateral flagella of A. hydrophila are O-linked glycosylated at least three times 
with a derivative of pseudaminic acid and there is evidence that this derivative is 
phosphorylated. It has been confirmed that mutation in flmA (pseB) or neuA (pseF) 
leads to the absence of both flagella which indicates that the biosynthesis of 
pseudaminic acid is essential for the productions of polar flagella and lateral flagella 
(Wilhelms et al. 2012). 
 
1.6 Connection between glycosylation in flagellin 
biosynthesis and LPS O-antigen biosynthesis  
Besides the flagellar systems, lipopolysaccharide (LPS) O-antigen which is an 
important pathogenic factor is also investigated in this project. 
 
LPS molecule which embedded in the outer leaflet of the outer membrane of 
many Gram-negative bacteria is an important part of bacterial cell envelope and this 
molecule also play a significant role in innate immune responses. LPS is consists of a 
lipid portion, a core oligosaccharide (OS) and an O-specific polysaccharide which is 
known as the O-antigen (Nikaido 1996; Whitfield and Valvano 1993). The 
surface-exposed LPS O-antigen which is required for the subsistence of bacteria 
prevents the cell from elimination by immune system (Tomás 2012). An 
understanding of the molecular mechanisms involved in production and modification 
of O-antigen can be very helpful for the development of new drugs and vaccines. 
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The surface-exposed O-antigen consists of repeating sequences of three to six 
sugar residues and the O-antigen is irreplaceable for the survival of bacteria because 
it protects bacteria from immune responses. The O-antigen need to be glycosylated 
before it is added to the LPS. The substrate of O-antigen glycosylation is 
CMP-Pse5Ac7Ac which is activated pseudaminic acid (Tomás 2012). In cytoplasm, 
Pse5Ac7Ac needs to be bound to CMP which is under the control of CMP-sugar 
synthetases including PseF (Cj1311) of C. jejuni and NeuA of A. caviae Sch3N to 
form CMP-Pse5Ac7Ac. Additionally, in A. caviae Sch3N, the CMP-Pse5Ac7Ac is the 
substrate of Lst and Lsg which were involved in LPS O-antigen formation (Tabei et al. 
2009). In A. caviae Sch3N, lsg and lst are located at the downstream of flm locus 
(Tabei et al. 2009). CMP-Pse5Ac7Ac is transfered onto a sugar-antigen carrier lipid 
(ACL) by Lst which is transferase and then the Pse5Ac7Ac-sugar-ACL complex is 
transported to the outer membrane by Lsg which is LPS-specific transporter 
(Kalynych et al. 2014). Eventually, Pse5Ac7Ac-sugar-ACL complex passes the 
cytoplasmic membrane with the help of Lsg and it is added to the inner-core of 
oligosaccharide for the purpose of generation of full functional LPS (Tabei et al. 2009) 
(Figure 1.4). 
 
Based on the papers published before, the glycosylations in LPS O-antigen 
biosynthesis and flagellin biosynthesis are cross correlated. In A. caviae Sch3N, the 
flagellin is O-glycosylated with Pse5Ac7Ac while LPS is glycosylated with the same 
sugar (Tabei et al. 2009; Parker et al. 2012). Based on the two mechanisms 
summarized above, it is clear that Pse5Ac7Ac is acts as a pivotal factor which 
connects the two mechanisms with glycosylation. Because of that, the investigation of 
the proteins related to Pse5Ac7Ac becomes very valuable. NeuA which directly 
interacts with Pse5Ac7Ac is a crucial target has been applied in this project. 
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Figure 1.5. The assumed flagellin glycosylation pathway and O-antigen 
formation in A. caviae Sch3N. 
This diagram shows NeuA and Maf1 are all involved in the proposed pathway of 
flagellin glycosylation and CMP-Pse5Ac7Ac is the key substrate connects the two 
mechanisms in A. caviae Sch3N (Tabei et al. 2009; Parker et al. 2012). 
 
1.7 Project aims and design 
The aim of this project is to investigate proteins associated with flagellar 
glycosylation in Aeromonas caviae. Maf1 the motility-associated factor is involved in 
polar flagellar biosynthesis and it is thought to be the glycosyl-transferase that directly 
transfer of pseudaminic acid onto the polar flagellin proteins in A. caviae Sch3N 
(Tabei et al. 2009; Parker et al. 2012). Hence the detail of how the Maf1 interacts with 
flagellin and which protein domains or amino residues that are directly related to these 
interactions are all interesting targets of this project. Furthermore, to prove that Maf1 
is indeed the glycosyl-transferase the substrate for the reaction need to be isolated or 
created, namely flagellin and the activated form of pseudaminic acid 
(CMP-Pse5Ac7Ac). Therefore, in order to create CMP-Pse5Ac7Ac, the Flm proteins 
of the pseudaminic biosynthesis pathway will be overexpressed and purified. Hence 
the biosynthesis of Pse5Ac7Ac and CMP- Pse5Ac7Ac can be looked into via these 
reactions. Flagellin proteins, are usually insoluble, previous work has shown that the 
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C-terminal chaperone binding domain of the A. caviae flagellin FlaA is not involved in 
the glycosylation process. Attempts will be made to create deletion derivatives of 
flagellin that are still glycosylated and are more soluble to provide more suitable 
substrate for future glycosylation assays. 
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Chapter 2 Methods and Materials 
2.1 Media 
All media are autoclaved to sterilize before use. 
2.1.1 Luria Bertani broth (LB broth) 
1% tryptone (Oxoid) 
0.5% yeast extract (Oxoid) 
1% NaCl (Melford) 
In dH2O 
 
2.1.2 Luria Bertani agar (LB agar) 
1% tryptone (Oxoid) 
0.5% yeast extract (Oxoid) 
1% NaCl (Melford) 
1.5% Bacteriological Agar 
In dH2O           
 
2.1.3 Brain heart infusion broth (BHIB) 
3.7% Brain Heart Infusion powder (Oxoid) 
In dH2O     
 
2.1.4 Tryptone soya agar (TSA) 
3.7% Tryptone Soya Agar powder (Oxoid) 
35 
 
In dH2O 
 
2.1.5 Motility agar 
0.5% tryptone (Oxoid) 
0.5% NaCl (Melford) 
0.25% agar (Oxoid) 
In dH2O 
 
2.1.6 X-gal agar 
1% Typtone 
0.5% Yeast Extract 
1% NaCl 
1.5% Agar  
In dH2O 
 
400μl of 2mg/ml X-gal (5-bromo-4-chloro-3-indolyl β-D-galactopyranoside) in 200ml  
200μl of 1M IPTG (isopropyl β-D-1-thiogalactopyranoside) in 200ml  
2.1.7 Blood agar 
horse blood agar plates (Oxoid) 
1.5% Proteose peptone 
0.25% Liver digest 
0.5% Yeast extract 
0.5% Sodium chloride 
1.2% Agar  
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2.2 Bacterial strains used in the study 
Table 2.1 Bacterial strains used in this study 
Name of strains Properties Reference 
Aeromonas caviae strains 
 
Sch3N 
 
Wildtype, NalR 
 
 
(Gryllos et al. 2001) 
Sch3N neuA::Km KmR and NalR，neuA knockout This study 
Sch3N flmA::Km KmR and NalR，flmA knockout This study 
Sch3N 
flaA::Km::flaB 
KmR and NalR ， flaA and flaB 
knockout 
This study 
Escherichia coli strains 
DH5α competent strain used in plasmid 
transformation 
Invitrogen Life 
TechnologiesTM 
S17-1 λpir SmR, Km::Tn7 (Tc::Mu) λpir, donor 
plasmid in conjugation 
(Miller 1972) 
BL21(DE3) T7 expression strain, used to 
express target genes 
Novagen 
NEB Versatile non-T7 expression strain, 
Protease deficient 
New England Biolabs 
(NEB) 
A. caviae Sch3N strains were incubated at 37℃ on LB agar and TSA or in LB 
broth and BHIB. Appropriate antibiotics were added when required and there is no 
antibiotics present in swarming agar. E. coli strains were grown at 37℃ on LB agar or 
in LB broth, in which antibiotics were added when required.  
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2.3. Plasmids used in the study 
    Table 2.2 Plasmids used in this study.  
Name of plasmids Characteristics Reference 
pBBR1MCS Broad-host-range plasmid, CmR (Kovach et al. 1994) 
pBBR1MCS-5 Broad-host-range plasmid, GmR (Michael E. Kovach a 
and a 1995) 
pKNG101 RK6 derived suicide plasmid, SmR   (Kaniga et al. 1991) 
pET28a Containing T7 promoter, N-terminal His 
tag, used for protein expression, KmR 
Novagen 
pMAL-c5x designed to produce maltose-binding 
protein (MBP) fusions, AmpR 
New England Biolabs 
(NEB) 
 
2.4. Antibiotics used in the study 
 Table 2.3 Antibiotics used in this study 
Antibiotics Working concentration Concentration made 
Kanamycin (Km) 50μg/ml 50mg/ml (dH2O) 
Streptomycin (Sm) 50μg/ml 50mg/ml (dH2O) 
Gentamicin (Gm) 25μg/ml 50mg/ml (DMSO) 
Chloramphenicol (Cm) 50μg/ml 50mg/ml (Ethanol) 
Ampcilin (Amp) 100 μg/ml 100 mg/ml (dH2O) 
Nalidixic acid (Nal) 30 μg/ml 30 mg/ml (dH2O) 
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2.5 – Growth conditions  
2.5.1 – Standard growth conditions 
The certain bacterial strain was incubated in 10 ml of the required growth media 
with appropriate antibiotics in a 25 ml sterile universal tube overnight with shaking. 
The optimal temperature for both E. coli and A. caviae cultures is 37⁰C.  
2.5.2 – Glycerol stock 
Glycerol stock was made by pipetting 500ul of the overnight culture of the 
selected strain which was prepared before into a 1.5 ml microcentrifuge tube 
containing 500ul of 50% glycerol. The stock was stored at -80⁰C. 
2.5.3 – Swimming motility assays 
Swimming motility assays were carried out by setting up an overnight culture of 
the selected strain. Motility agar was prepared following 2.15 motility agar protocol. 
The motility agar was prepared before using. The assays were carried out on motility 
agar plates. 1 ml of the overnight culture was centrifuged (13,000xg) in a 1.5 ml 
microcentrifuge tube (Sigma) for 1 minute and the supernatant was discarded. About 
10μl of the pellet was directly injected into the center of the motility agar by pipette. 
Swimming motility plates were incubated overnight at room temperature and 
swimming motility was analysed by measuring the radius of any motility halos appear. 
 
2.6 Chromosomal DNA extraction 
Bacteria growth was gained from overnight culture in 10ml LB broth with 
appropriate antibiotics. The culture was centrifuged at 1,600xg for 15 minutes at room 
temperature. The supernatant was discarded and the cell pellet was resuspended in 
500μl of lysozyme. The sample was incubated in water bath at 37℃ for 60 minutes. 
Then 50μl of 10%SDS was added and mixed with the sample and the sample was 
vortexed until it was viscous or creamy. After that, the sample was incubated in water 
bath for 15 minutes at 37℃.Then the sample was vortexed again until viscosity was 
decreased.  
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After that, 300ul phenol/chloroform was added and the sample was centrifuged at 
1600xg for 10 min. aqueous layer (top) was transferred into a fresh Eppendorf tube 
and 200μl dH2o and 300μl phenol/chloroform were mixed with the aqueous layer. This 
procedure was repeated twice with phenol-chloroform and dH2o. A 1/10 volume of 3M 
sodium acetate and 1 volume of ice-cold isopropanol were added and mixed by 
inversion. Then the sample was left on ice for 10-20 minutes and centrifuged at 
1,600xg for 15 minutes. The supernatant was discarded and the sample was mixed 
with 0.5ml of 70% ethanol and centrifuged at 13,000xg for 1 minute and the 
supernatant was discarded. This procedure was repeated once with 0.5ml of 70% 
ethanol. The DNA pellet was left to dry for at least 2 hours and resuspend in 50μl of 
dH2O.  
 
2.7 Polymerase chain reaction (PCR)  
Polymerase chain reaction (PCR) was applied in 50μl mix containing reagents of 
PCR in thin-walled PCR tubes using an Invitrogen T100TM Thermal Cycler (PCR 
machine). The PCR reaction mixtures used in this project were listed as follows: 
 
2.7.1 Normal PCR and SOE PCR condition 
10X Pfx Amplification Buffer (invitrogen)                                  5μl 
2mM dNTPs                                                    5μl 
50mM MgCl2                                                   2μl 
Pr imers                                               1μ l  +1μ l 
Polymerase (Platinum Pfx)                                              0.5μl 
Template DNA                                               1μl 
dH2O was added up to 50μl of total volume 
2.7.2 Colony PCR screen condition 
5X GoTaq Buffer (PROMEGA)                                   10μl 
2mM dNTPs                                               5μ l 
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50mM MgSO 4                                              2μ l 
D M S O                                                 2 μ l 
Pr im e r s                                             1μ l  + 1μ l  
Polymerase (GoTaq DNA Polymerase)                                     .5μl 
dH2O was added up to 50μl of total volume. 
Bacterial colonies were taken out by clean tips as templete DNA and these colonies 
were transferred into each tube separately. 
 
2.7.3 PCR cycles 
PCR conditions for Normal PCR (Pfx), SOE PCR (Pfx) and Colony PCR (Taq) are 
listed in table 2.4. Annealing temperature was adjusted according to different primers 
and Extension time was determined according to the length of the PCR fragment 
following the manufacturer’s instructions. 
 
Table 2.4 PCR conditions for different polymerase.  
Name of step Taq polymerase Pfx polymerase 
Heated lid 105℃ 105℃    
Denaturing 1 cycle 95℃     3min 94℃     3min 
Denaturing 30 cycles 95℃    40sec 94℃    40sec 
Annealing 30 cycles 55℃    30sec 56℃    30sec 
Extension 30 cycles 72℃ 68℃ 
Final extension 1 cycle 72℃     2min 68℃     2min 
Infinite Hold  4℃ 5℃ 
 
2.7.4 – DNA sequencing 
DNA was sent to be sequenced by the Genomic Medicine Service at the Medical 
School of Sheffield University. FinchTV, SnapGene and BLAST (online resource) 
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were applied for sequencing and checking DNA products.  
2.8 Isothermal Assembly (ISA) 
The ISA was designed to join several DNA fragments into one plasmid in a single 
reaction and each fragment applied in ISA contained an approximately 40bp adapter 
sequence overlapping each other. The concentrations of DNA fragments were 
measured by using nanodrop. Then an appropriate amount of each DNA fragment 
was added into an Eppendorf tube and all DNA fragments were mixed with ISA Buffer 
and three enzymes including T5 exonuclease, Phusion polymerase and Taq ligase. 
After incubation for 1 hour at 50°C, the mixture was transformed into E. coli DH5α and 
cells were spread on agar containing the appropriate antibiotic to recover bacteria 
containing the plasmid. 
2.8.1 5X ISA Buffer (1ml) 
1M Tris-HCl pH 7.5                                                500μl 
2M MgCl2·6H2O                                                   25μl 
100mM dATP                                                      10μl 
100mM dTTP                                                      10μl 
100mM dCTP                                                     10μl 
100mM dGTP                                                     10μl 
1M DTT                                                          50μl 
PEG-8000                                                      0.25μl 
100mM NAD                                                      50μl 
dH2O                                                            335μl 
 
2.8.2 ISA reaction (5 tubes) 
5X ISA Buffer                                                      20μl 
Diluted T5 exonuclease (10 units)                                    0.5μl 
Phusion Polymerase (1 unit)                                     1.25μl 
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Taq Ligase (80 units)                                        10μl 
dH2O                                                           43.3μl 
The reagent was aliquot into 5x 15μl in each reaction 
 
2.9 Agarose gel electrophoresis 
2.9.1 Preparation of 1X TAE (pH 8.0) 
40 mM Tris (Fisher) 
1.142% Acetic acid (Melford) 
1 mM EDTA (Melford) 
2.9.2 Preparation and electrophoresis of agarose gels 
100ml 1X TAE Buffer was mixed with 1g of agarose powder to make 1% agarose 
gel and the mixture was heated in a microwave for 3-5 minutes until the agarose 
powder was dissolved. Then the liquid agarose gel was poured into a gel tray which 
was sealed at both ends with rubber caps and a comb was placed in the agarose gel 
to make wells. The agarose gel was left to solidify for 15-25 minutes. After the gel was 
solid, the tray was put into a gel tank filled up with 1X TAE buffer. The DNA samples 
with loading dye (5:2) and corresponding DNA ladder (Appendix 1) were loaded into 
the gel wells. The agarose gel was run at 100V for 60 minutes and then stained with 
ethidium bromide (0.5μg/ml) for 15 minutes. After that, the gel photo was taken on an 
ultraviolet trans-illuminator. 
 
2.9.3 Gel extraction using QIAgen agarose gel extraction 
kit 
The DNA fragment was excised from the ethidium bromide stained agarose gel 
with a specific tip under ultraviolet light. The gel slice was weighed in a colourless 
tube. 3 volumes of Buffer QG to 1 volume of the agarose gel (100mg~100μl) was 
added and the mixture was incubated at 50°C for 10 minutes and mixed by inverting 
for several times until the gel slice was completely dissolved. The colour of the 
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mixture should be yellow. If the colour of mixture was orange or violet, 10μl of 3M 
sodium acetate (pH 5.0) was added. Then 1 volume of isopropanol to the mixture was 
added and mixed. To bind DNA, the sample was applied to the QIAquick column and 
centrifuged for 1min at 13000xg and the flow-through was discarded. To wash the 
DNA, 750μl of Buffer PE wash buffer was added and the sample was centrifuged for 1 
min at 13,000xg and the flow-through was discarded too. Then the sample was 
centrifuged again for 1min at 13,000xg to remove residual wash buffer. To elute the 
DNA fragment, 30μl of Elution Buffer was added to the centre of the spin column and 
the desired DNA fragment was obtained after centrifugation for 1 min at 13000xg. 
Buffer QG, PE wash buffer and Elution Buffer were provided by QIAgen agarose gel 
extraction kit. 
 
2.10 Restriction enzyme digestion 
The digestion was set up with the required restriction enzyme and corresponding 
buffer. All reagents were mixed together following the reaction conditions in 2.10.1. 
The mixture was incubated at 37℃ for 3-4 hours. After the incubation, the sample was 
purified following the PCR purification protocol in 2.11. 
 
2.10.1 Reaction conditions: 
DNA samples                                             5μl-16μl  
Restriction enzyme (10u/μl)                                           1μl 
10X Buffer                                                      2μl 
dH2O was added up to 20μl of total volume. 
2.11 PCR purification using the QIAgen PCR 
purification kit 
The PCR product was transferred into an Eppendorf tube and mixed with 500μl of 
Buffer PB. The mixture was then transferred into a QIAquick spin column which was 
placed in a provided 2ml collection tube and the tube was centrifuged at 13,000xg for 
1 minute. The flow-through was discarded and the column was placed back into the 
same collection tube. To wash the sample, 600μl of Buffer PE was added to the 
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column followed by centrifugation at 13,000xg for 1 minute. The flow-through was 
discarded and the column was placed back again. Then the collection tube was 
centrifuged at 13,000xg for 1 minute again to remove residual wash buffer and the 
column was transferred into a new Eppendorf tube. To elute the sample, 20-50μl of 
Buffer EB was added to the centre of the column membrane and the Eppendorf tube 
was centrifuged at 13,000xg for 1 minute. Buffer PB, Buffer PE and Buffer EB were 
provided by QIAgen PCR purification kit. 
2.12 Mini-preparation of plasmid DNA (using QIAgen 
plasmid extraction kit) 
The cells were cultured in 10ml LB broth with appropriate antibiotics at the 37℃ 
with shaking for 12 hours before plasmid extraction. To harvest the cells, the sample 
was centrifuged at 1,600xg for 15 minutes at room temperature to pellet the cells. The 
supernatant was discarded and the cell pellet was resuspended in 250μl of Solution 
1/RNase A solution. The sample was then transferred into an Eppendorf tube and 
250μl of Solution 2 was added and mixed by gently inversion and rotation. Then the 
sample was incubated for 2 minutes at room temperature. After that, 350μl of Solution 
3 was added and immediately mixed with the sample by inversion. 
 
The sample was centrifuged at 13,000xg for 10 minutes at room temperature and 
the supernatant was transferred to the QIAprep spin column. The sample was then 
centrifuged at 13,000xg for 1 minute and the flow-through was discarded. A volume of 
500μl of Buffer PB was added followed by centrifugation at 13,000xg for 1 minute and 
the flow-through was discarded. A volume of 600μl of Buffer PE was added followed 
by centrifugation at 13,000xg for 1 minute and the flow-through was discarded. The 
sample was centrifuged at 13,000xg again for 1 minute to remove residual wash 
buffer. The QIAprep spin column was placed into a new Eppendorf tube, to elute the 
sample, 50μl of Buffer EB was added to the centre of the column membrane and the 
Eppendorf tube was centrifuged at 13,000xg for 1 minute. Solution 1/RNase A 
solution, Solution 2, Solution 3, Buffer PB, Buffer PE and Buffer EB were provided by 
QIAgen plasmid extraction kit. 
 
2.13 Ligation 
Ligation reaction was set up with T4 DNA ligase (50 units) (Promega) and Ligase 
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Buffer. Purified linear plasmids (30-50μg/μl) and purified PCR fragments (80-100μg/μl) 
with corresponding restriction sites on both terminals were added to be ligated. The 
ligation reaction conditions are shown in the table below. All samples and controls 
were incubated for 12 hours at 15℃. 
 
Table 2.5 Ligation reaction conditions. 
Name of reagant Ligation 
Reaction 
+Ligase Control -Ligase Control 
Linear Plasmid (30-50μg/μl) 2μl 2μl 2μl 
Target DNA fragment 
(80-100μg/μl) 
6μl 0μl 0μl 
Ligase Buffer 1.5μl 1.5μl 1.5μl 
Ligase (10-20μg/μl) 1μl 1μl 0μl 
dH2O Added up to 15ul of total volume 
 
2.14 Preparation of competent cells 
E. coli (DH5α, BL21 and S17-1 λpir) were cultured overnight in 10ml LB broth 
with appropriate antibiotics at 37℃. 1ml of bacterial cells in LB broth was transferred 
into 100ml of sterile LB broth to make a 1:100 dilution. Then the culture was shaken at 
37℃ for 2-4 hours until the OD600nm of the culture reached 0.3 (approx. 4-7 x 10
7 
cfu/ml). Then the culture was collected into two 50ml universal tubes and kept on ice 
for 15 minutes followed by centrifugation at 1,600xg for 20 minutes at 4℃. Then the 
cell pellets were resuspended in 33ml (1/3 of the original volume) of RF1 solution and 
the cells were incubated on ice for 15 minutes followed by centrifugation at 1,600xg 
for 20 minutes at 4℃. The cell pellet was then resuspended in 8ml (1/12.5 of the 
original volume) of RF2 solution and the cells were incubated on ice for 15 minutes. 
After that, the cells were aliquoted into chilled sterile Eppendorf tubes (200μl) and 
stored at -80℃. 
 
RF1 solution                                RF2 solution 
100mM KCl                                 10mM MOPS buffer pH 6.8 
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50mM MnCl2                                10mM KCl 
30mM Potassium acetate                     75mM CaCl2·2H2O 
10mM CaCl2·2H2O                           15% glycerol (w/v) 
 
 
2.15 Transformation 
A volume of 100μl of competent cells was added into a sterile Eppendorf tube 
and 5-20ul of plasmid DNA was added to the Eppendorf tube and the cells were 
mixed with plasmid DNA. The Eppendorf tube was left on ice for 30 minutes. Then the 
cells were heat shocked in a 42℃ water bath for 90 seconds. After that, 1ml of LB 
broth was added into the Eppendorf tube and the sample was incubated at 37℃ for 1 
hour. The cell culture (150μl) was then spread on LB agar plates with appropriate 
antibiotics. The cells were incubated overnight at 37℃. 
 
2.16 Bacterial conjugation 
Bacterial strains were cultured overnight in 10ml LB broth with appropriate 
antibiotics at 37℃ with shaking. The cell cultures were centrifuged at 1,600xg for 15 
minutes to collect the cells. The supernatants were discarded and the pellets were 
resuspended in 5ml of steriled PBS Buffer. To wash the cells, the suspensions were 
centrifuged at 1,600xg for 15 minutes and the supernatants were discarded. The cell 
pellet of conjugal bacterial strain (donor) was resuspended in 1ml of sterile PBS Buffer. 
0.5ml of the suspension of the conjugal bacterial strain (donor) was mixed with the 
pellet of the conjugal bacterial strain (recipient). 200μl of the mixed strains were plated 
onto blood agar plate. The plate was incubated at 37°C for 8 hours. Then the cells 
were scraped off the blood agar with 1ml of PBS Buffer. Serial dilutions (10-3 and 10-4) 
were made and 200ul of each strain was spread onto LB agar plates with appropriate 
antibiotics. The plates were incubated overnight at 37°C to select colonies with the 
desired resistance. 
 
Phosphate Buffered Saline (PBS) Buffer 
1 tablet of PBS (SIGMA™) in 200ml dH2O 
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200ml of PBS containing: 
10mM Phosphate buffer 
2.7mM KCl 
137mM NaCl 
 
2.17 Lipopolysaccharide (LPS) extraction 
Bacterial cells were obtained from overnight LB broth culture grown at 37°C. 3ml 
of the culture was washed once in PBS Buffer and then centrifuged at 10,000xg for 3 
minutes. The supernatant was discarded. The pellet was mixed with 1ml of PBS 
Buffer and vortexed. After that, the suspension was centrifuged at 13,000xg for 1 
minute and the PBS solution was discarded. The pellet was resuspended in PBS 
Buffer until the A600 of suspension reached 1.0. The bacterial suspension was then 
centrifuged at 10,000xg for 3 minutes and resuspended in 200µl dH2O. 200µl of 90% 
(w/v) phenol solution was added into the bacteria suspension and the mixture was 
vortexed and incubated for 10 minutes at 37°C. The mixture was kept on ice for 2 
minutes followed by centrifugation at 2,300xg for 5 minutes. The upper liquid phase 
was collected and mixed with 1 volume of Lysis buffer and boiled for 5 minutes. The 
extracts were stored at -20°C. The sample was usually loaded in an SDS-PA gel and 
stained following the silver stain protocol (section 2.18). 
 
2.18 Silver stain (Silver stain kit) 
The SDS-PAGE gel was washed twice for 5 min with ultrapure water and fixed 
twice for 15 min in 30% ethanol and 10% acetic acid solution. Then the gel was 
washed twice for 5mins in10% ethanol and washed twice with ultrapure water for 5 
min. After that, the gel was sensitized in Sensitizer Working solution for 1 min and 
washed twice with ultrapure water for 1 min. Then the gel was stained in Stain 
Working solution for 30 min. Then the gel was washed twice with ultrapure water for 
20 sec and developed in Developer Working solution for 2-3 min until the bands were 
observed. Then the gel was stopped with 5% acetic acid for 10 min. Sensitizer 
Working solution, Stain Working solution and Developer Working solution were 
provided by Silver Stain kit. 
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2.19 Protein overexpression  
The E. coli protein expression strain (BL21(DE3)) containing the plasmid of 
interest was incubated overnight at 37°C with shaking in 10ml LB broth with 
appropriate antibiotics. 5ml of the overnight culture was transferred into 500ml of LB 
broth with appropriate antibiotics on second day. The culture was incubated at 37°C 
for 2 - 4 hours until the OD600 reached 0.6-1.0 and 500µl of 1M IPTG was added to 
induce the protein expression. After overnight incubation at 37°C with shaking, the 
cells were harvested by centrifugation at 5,000xg for 15 min at 4°C. The supernatant 
was discarded and the pellet was resuspended in 25ml Binding Buffer or Column 
Buffer and stored at -20°C. Then the sample was sonicated 5 - 6 times using Jencons 
Vibracell at 20 kHz (20% amplitude) for 30 seconds with 1 min intervals on ice. The 
sonicated sample was then centrifuged at 12,000xg for 15 minutes at 4°C to separate 
soluble and insoluble proteins. The supernatant which contained soluble proteins was 
stored in a new universal tube at -20°C and the centrifuge tube which contained the 
pellet was also stored at -20°C. 
 
2.19.1 Binding Buffer preparation 
Binding Buffer (50ml) 
25mM Tris-Cl pH 7.4                      1.25 ml of 1M Tris-Cl stock solution 
10mM Imidazole pH7.4                  0.25ml of 2M imidazole stock solution 
400mM NaCl   pH7.0                    4ml of 5M NaCl stock solution   
 
2.20 Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
2.20.1 Preparation and electrophoresis of polyacrylamide 
gel 
Polyacrylamide gel consisted of resolving gel and stacking gel. The resolving gel 
was prepared firstly and poured into the electrophoresis device. It takes about 5 
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minutes to become solid. Then the stacking gel was prepared and poured into the 
electrophoresis device and a comb was inserted into the gel to make wells. The 
stacking gel takes about 5 min to become solid. The components of these gels are 
listed in the Table 2.7 
 
The protein samples were prepared by boiling with an equal volume of Laemmli 
Buffer at 100°C for 5-10 minutes. To each well of SDS-PA gel, 20µl of the sample was 
loaded and corresponding protein ladder is shown in Appendix 1. The gel was run at 
160V for 90-120 minutes in 1X SDS Running Buffer. After that, the gel was stained 
with Coomassie Blue Stain Solution for 12 hours and then destained with Destain 
Solution until the bands were clear. 
 
Table 2.6 SDS-PAGE Resolving Gel components (Pour first).  
%Gel Acrylamide 
(30% w/v) 
Tris (1.5M 
pH 8.8) 
H2O TEMED  APS 
(10% 
w/v) 
SDS 
(10% 
w/v) 
5 1.65ml 2.5ml 5.65ml 7µl  200µl 100µl 
10 3.3ml 2.5ml 4.0ml 7µl  200µl 100µl 
12 4.0ml 2.5ml 3.3ml 7µl  200µl 100µl 
14 4.66ml 2.5ml 2.64ml 7µl  200µl 100µl 
15 5.0ml 2.5ml 2.3ml 7µl  200µl 100µl 
 
Table 2.7 SDS-PAGE Stacking Gel components (Pour last).  
Acrylamide 
(30% w/v) 
Stacking buffer H2O TEMED APS (10% 
w/v) 
0.68ml 1.25ml 3ml 5µl 50µl 
 
The percentage of resolving gel used was dependent upon the expected size of 
the protein sample. 12% of resolving gel was used in this project to check the 
products of protein overexpression and protein purification. 
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2.20.2 Buffer preparation 
Tris (1.5M pH 8.8)                          45.43g in 250ml of dH2O 
 
Laemmli Buffer 
62.5mM Tris (pH 6.8) 
2% (w/v) SDS 
5% (v/v) β-Mercaptoethanol 
10% (v/v) Glycerol 
0.02% (w/v) Bromophenol Blue 
 
10X SDS Running Buffer (pH 8.3)                     Amount for 1 litre dH2O 
250mM Tr is-Base                                       30.2g  
1.92M Glyc ine                                          144g   
1% (w/v) SDS                                            10g  
 
Coomassie Blue Stain Solution (1L) 
500ml Methanol 
2.5g Coomassie Blue 
100ml Acetic acid 
dH2O added up to 1L 
 
Destain Solution (1L) 
400ml Methanol 
100ml Acetic acid 
dH2O added up to 1L 
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2.21 Histidine-tagged protein purification protocol  
2.21.1 Column preparation 
The HisTrapTM HP Column was washed with 5ml distilled H2O and equilibrated 
with 10ml binding buffer. 
 
2.21.2 Purification protocol 
The supernatant which contained soluble proteins (Load) was taken out from the 
-20°C freezer and the sample was prepared by filtration through a 0.45μm filter to 
remove any debris and the flow-through (FT) was collected. Then the protein sample 
was applied to the HisTrapTM HP Column using a flow rate of 1-3 ml/min and the 
flow-through (Wash) was collected. The proteins with His-tag were all bound to the 
nickel ions in the column. The column was washed with 10ml binding buffer. The 
proteins with His-tag were then eluted with 5ml Binding Buffer with increasing 
imidazole concentration (50mM to 500mM) in 1ml fractions. All fractions were 
checked by SDS-PAGE including the sample Load, sample FT and sample Wash. 
From each sample, 20ul was taken and mixed with 20ul of Laemmli buffer. Then all 
the mixtures were boiled for 10 minutes and checked by SDS-PAGE. 
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Table 2.8 Binding Buffer with increasing concentration of imidazolea.  
Imidazole 
concentration 
2M imidazoleb 
(ml) 
1M Tris-Cl (ml) 5M NaCl (ml) dH2O (ml) 
50mM 0.5 0.5 1.6 17.4 
100mM 1 0.5 1.6 16.9 
150mM 1.5 0.5 1.6 16.4 
200mM 2 0.5 1.6 15.9 
250mM 2.5 0.5 1.6 15.4 
300mM 3 0.5 1.6 14.9 
400mM 4 0.5 1.6 13.9 
500mM 5 0.5 1.6 12.9 
(a) Binding Buffer was prepared according to protocol 2.19.1. 
(b) 2M Imidazole stock was prepared by dissolving 6.8g imidazole in 50ml 
dH2O and adjusted to pH 6.8. 
2.22 MBP-tag protein purification protocol 
2.22.1 Column preparation 
The MBPTrapTM HP Column was washed with 5ml distilled H2O and equilibrated 
with 10ml column cuffer. 
 
2.22.2. Purification protocol  
The supernatant which contained soluble proteins (Load) was taken out from the 
-20°C freezer and the sample was prepared by filtration through a 0.45μm filter to 
remove any debris and the flow-through (FT) was collected. Then the protein sample 
was applied to the MBPTrapTM HP Column using a flow rate of 1-3 ml/min and the 
flow-through (Wash) was collected. The proteins with MBP-tag were all bound to the 
beads in the column. The column was washed with 10ml binding buffer. The proteins 
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with His-tag were then eluted with 5ml column binding buffer with increasing maltose 
concentration (20mM to 300mM) in 1ml fractions. All fractions were checked by 
SDS-PAGE including the sample Load, sample FT and sample Wash. From each 
sample, 20ul was taken and mixed with 20ul of Laemmli buffer. Then all the mixtures 
were boiled for 10 minutes and checked by SDS-PAGE. 
 
2.22.1 Column Binding Buffer preparation  
Column buffer:                                          Amount per litre dH2O              
20 mM Tris-HCl                                     20 ml 1 M Tris-HCl (pH 7.4) 
200 mM NaCl                                                     11.7 g NaCl 
1 mM EDTA                                                2.0 ml 0.5 M EDTA 
 
2.23 Western Blotting 
After SDS-PAGE, one of the two gels was applied to be analysed by Western 
Blot.  
 
The gel was placed in a western blotting cassette (BIO-RAD™) along with a 
nitrocellulose membrane (Whatman™ 0.45μm pore size) for proteins to be transferred 
onto and 3 filter papers of similar shape with the gel. The blotting cassette was 
assembled and placed in a tank filled up with 1X Transfer Buffer and run at 10V 
overnight. The blotting cassette was set up to direct the proteins passed from the gel 
towards the membrane. Then the membrane was collected and soaked in 20ml of 5% 
(w/v) skimmed milk solution (Marvel™) for 1hour to block all non-specific binding sites. 
Then the membrane was washed in 20ml PBS Buffer for 10 min. After that, the 
membrane was soaked in 20ml of 5% (w/v) skimmed milk solution in which 1-5μl 
(1:2000) of primary antibody was added for 1 hour. Then the membrane was washed 
3 times in 10ml of PBS solution for 5 minutes. To bonded by the secondary antibody, 
the membrane was soaked in 20ml of 5% (w/v) skimmed milk solution in which 1-5μl 
(1:4000) of secondary antibody was added for 1 hour. Then the membrane was 
washed 3 times in 10ml of PBS Buffer for 5 minutes again. 
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To develop the membrane, Pierce™ ECL Western Blotting Substrate (Thermo 
Scientific™) was applied. 1ml of Detection Reagent 1 (Peroxide Solution) was mixed 
with 1ml of Detection Reagent 2 (Luminol Enhancer Solution) before using and the 
mixture was poured on the membrane. The western blot photo was taken using 
Chemidoc™ XRS+ System (Bio-Rad™). 
2.23.1 Buffer preparation 
10X Transfer Buffer (1L) (pH 9.0) 
Glycine                                                          144g 
Tris-Base                                                        30.2g 
dH2O added up to 1L 
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Chapter 3 Investigation of glycosylation in 
flagellin biosynthesis 
3.1 Introduction 
The flagellum consists of a basal body, the hook-associated proteins and the 
filament and they are essential for bacterial motility. The flagella filament is composed 
of a polymer of flagellin proteins. There are two polar flagellins (FlaA and FlaB) and 
two lateral flagellins (LafA1 and LafA2) expressed in A. caviae. In A. caviae Sch3N, 
flagellins of the polar flagella are glycosylated 6 to 8 times by Pse5Ac7Ac using the 
enzyme Maf1 which is known to be a flagellin glycosyl transferase (Parker et al. 
2012).  
 
The structure of flagella filament from Salmonella typhimurium has been 
described and the structure of the flagellin is similar in all bacteria. Starting from the 
N-terminus there are four domains including D0, D1, D2 and D3. The C-terminal chain 
folds back to D0 to form a coiled coil (Figure 3.1). The D0 and D1 are basically buried 
inside of the structure of the filament while the central D2 and D3 domains are 
exposed at the surface when the filament is polymerised. The D2 and D3 domains are 
considered to be recognized by glycosyltransferase in bacteria such as A. caviae, 
although they are not glycosylated in Salmonella (Tabei et al. 2009; Yonekura et al. 
2003). These findings suggest that the D2 and D3 are where the flagellar 
glycosylation occurs. A recent study in A. caviae suggests that Maf directly binds the 
flagellin and is responsible for glycosylation, it does this in a chaperone independent 
manner, as deletion of the chaperone or removal of the chaperone binding domain on 
the flagellin still results in glycosylated flagellin. Although the flagellin is not secreted. 
 
The fla locus of A. caviae Sch3N is linked to the biosynthesis of polar flagella 
filament. This locus includes the genes flaA, flaB, flaG, flaH and flaJ which have been 
listed in genetic order (Rabaan et al. 2001). The flaA and flaB genes of A. caviae 
Sch3N encode two flagellin subunits. Strains that lack flaA and flaB show no motility 
and further study proved that production of polar flagellins in this strain is absolutely 
terminated (Rabaan et al. 2001). Motility and adherence drop to about 50% in the 
strain with single mutation in either flaA or flaB in which flagella are still expressed. 
This finding indicates that flaA and flaB compose flagellin with a 1:1 ratio (Rabaan et 
al. 2001). 
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In conclusion, glycosylation and assembly of flagellins of polar flagella in A. 
caviae Sch3N can be described like this: The original flagellin synthesized from FlaA 
and FlaB has a central D2/D3 domain that is glycosylated by Maf and a C-terminal 
chaperone-binding domain (CBD) which can directly interact with the chaperone FlaJ. 
It is not known where Maf binds the flagellin, but it does not appear to be the CBD as 
the removal of the CBD still results in a glycosylated flagellin. However, Maf 
glycosylates the central D2/D3 domain of the flagellin with Pse5Ac7Ac using the 
activated form of CMP-Pse5Ac7Ac as a substrate (Tabei et al. 2009; Yonekura et al. 
2003). 
 
Maf1 is thought to be bound to the central D2/D3 domain of the flagellin and uses 
CMP-Pse5Ac7Ac to glycosylate the flagellin with Pse5Ac7Ac. After that, Maf1 is 
released from the glycosylated flagellin for the next circulation (Parker et al. 2012). 
Secondly, as it was mentioned before, FlaJ is bound to the C-terminal 
chaperone-binding domain (CBD) of glycosylated flagellin (FlaA /FlaB+Pse) and this 
complex is transported to the basal body of flagellum. Finally, the glycosylated 
flagellin is discharged from intracellular environment via flagellar specific T3SS. The 
exported flagellin will be polymerized by FlaH the cap protein at the distal tip and the 
complete flagellar filament will be produced. Glycans can attach to the surface of the 
filament after flagellin is folded (Parker et al. 2012; Parker et al. 2014) (Figure 3.1). 
 
Therefore, in this chapter we wished to determine, how much of the C-terminal 
domain of the flagellin could we remove before glycosylation stopped, this would allow 
further mapping of the flagellin for glycosylation purposes. 
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Figure 3.1 Cartoon of the structure of the flagellin subunit. 
The flagellin subunit is composed of several domains, the D0 domain is 
composed of two alpha helices at both the N and C-terminal end of the polypeptide, 
as is the D1 domain. These two domains are internalized in the polymerized filament. 
The D2 and D3 domains make up the surface exposed areas of the filament and are 
the ones that are glycosylated. 
 
3.2 Construction of A. caviae flaA-flaB mutant 
In order to investigate the properties of a series of flagellin deletion constructs in A. 
caviae from the plasmid pBBR1-MCS (Cm
R
), an Aeromonas caviae flagellin negative 
background strain needed to be created. The previous one described by Rabaan 2001 
had insertions in both FlaA and FlaB, carrying chloramphenicol resistance and kanamycin 
resistance respectively. Therefore, it was decided to create an insertional deletion mutant 
strain in which part of both flaA and flaB were deleted and replaced with the selectable 
kanamycin resistance marker. 
 
In order to create this mutant, 2 DNA fragments including flaA1 and flaB2 were 
designed and obtained by PCR first and these DNA fragments represented the 5’ portion 
of flaA and 3’ portion of flaB respectively as shown in Figure 3.3. A kanamycin resistance 
cassette which is a PCR amplified Tn5-derived kanamycin resistance cartridge (nptII)) 
was also isolated. Subsequently the mobilizable suicide plasmid carrying streptomycin 
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resistance pKNG101 was digested using the restriction enzyme BamHI (Figure 3.2). All 
DNA fragments were substrates for isothermal assembly. 
 
The DNA fragments and plasmid used in Isothermal Assembly are listed in Table 3.1. 
The concentrations of all DNA samples were measured using nanodrop to ensure they 
were equimolar. After that, ISA was applied and the reaction mix was transformed into E. 
coli CC118λpir to be selected (SmR and KmR). Resistant colonies were isolated and the 
possible recombinant vectors were analysed by PCR screening using primers including 
flaAISAF1 and flaBISAR2 (section 2.7.4) (Figure 3.4). Then the selected 
pKNG101::flaA::Km::flaB (Figure 3.2) was confirmed by DNA sequencing and 
retransformed into E. coli S17-1 λpir for the conjugation with A. caviae Sch3N (NalR). The 
strains obtained from conjugation were resistant to nalidixic acid and kanamycin and were 
replica plated on two TSA plates. They were tested to see if they were oxidase positive 
(Aeromonas) versus negative (E. coli) One TSA plate contained Nal and Km, the other 
plate contained Km and Sm. Strains that were Km resistant but Sm sensitive, were 
thought to have undergone allelic exchange through a double homologous recombination 
event. Those were subsequently checked by a diagnostic PCR using primers including 
flaAISAF1 and flaBISAR2 to confirm the result (Figure 3.5). This resulted in the flaA-flaB 
mutant strain A. caviae Sch3N flaA::Km::flaB. 
 
The size of PCR product using flaAISAF1 and flaBISAR2 as primers and A. caviae 
Sch3N (WT) genomic DNA as template is about 2500 bp. The size of PCR product 
using flaAISAF1 and flaBISAR2 as primers and A. caviae flaA::Km::flaB genomic DNA 
as template is about 2600 bp. There is a restriction cutting site which can be 
recongnized by HindIII between flaA gene and flaB gene in A. caviae Sch3N and this 
restriction cutting site is removed in A. caviae flaA::Km::flaB. In order to tell the 
difference between the above two PCR products, both of the PCR products were 
digested by HindIII. It can be observed that the PCR product (2500 bp) using A. 
caviae Sch3N (WT) genomic DNA as template was digested while the PCR product 
(2600 bp) using A. caviae flaA::Km::flaB genomic DNA as template was not digested. 
This result indicates that the flaA and flaB genes in A. caviae flaA::Km::flaB were 
knocked out by kanamycin resistance cassette insertion (Figure 3.5B). 
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Table 3.1 DNA fragments and plasmid used in ISA and primers of flaA1 and 
flaB2. Complementary termini of 40bp sequence homology were added to the 
original Km cassette, flaA1 and flaB2 genes. 
Names Sizes 
(bp) 
Primers 
flaA1 676 bp flaAISAF1: 5’ CCCCCCCCCTGCAGGTCGACGGATCTCAATACCAACGTTTCATCGC 
flaAISAR1: 5’ TCAAACATGAGAACCAAGGAGAATACTCTGAGTGCTAATACTGATCC 
flaB2 510 bp flaBAISAF2:5’ GTTTTAGTACCTAGCCAAGGTGTGCTTAGCTTGTCTCAAGCCGGAG 
flaBISAR2: 5’ GCTGCTCCTCATATCAATGATGTTGACGTTAAGGCCCGCTTAACCCAGCAGCTGCAG 
Km cassette 1492bp Kmfor: 5’ TTCTCCTTGGTTCTCATGTTTGACAGCTT 
Kmrev: 5’ GCACACCTTGGCTAGGTACTAAAACAATTC 
pKNG101 6986bp N/A 
pKNG101::flaA:
:Km::flaB 
9585bp N/A 
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(B)  
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Figure 3.2 Isothermal assembly (ISA) method for construction of 
pKNG101::flaA::Km::flaB and construction of A. caviae flaA::Km::flaB 
(A) This plasmid was constructed using Isothermal assembly of the 676bp 5’ flaA1 
fragment the 1492bp KmR cassette, and the 510bp 3’ flaB2 fragment assembled into 
BamHI digested pKNG101. The PCR fragments flaA1 and flaB2 were generated with 
primers that had overhangs with the pKNG101 and kanamycin cassette (flaA1) and 
the kanamycin cassette and pKNG101 (flaB2) respectively. The four DNA fragments 
flaA1, KmR, flaB2 and pKNG101 were mixed together at equimolar concentrations 
and assembled together using ISA. 
 
(B) A diagrammatic representation of allelic exchange between the suicide vector 
construct pKNG101::flaA::Km::flaB and the flaA and flaB genes on the chromosome 
of A. caviae Sch3N following transfer of suicide plasmid from E. coli CC118λpir into 
the Aeromonas cells. Potential double crossover mutants were selected by replica 
plating. Each colony was patched on to two LB agar plates, one with kanamycin and 
nalidixic acid and the other one with kanamycin and streptomycin. Those that were 
streptomycin sensitive were taken for further investigation. The features of the 
plasmid vector are shown by arrows, the flaA gene is shown by a blue arrow, the flaB 
gene is shown by a green arrow and the Km cassette is shown by a grey arrow. The 
figure was created using SnapGene®software. 
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  1     2     3 
 
Figure 3.3 Analysis of PCR products following amplification of flaA gene 
fragment and flaB gene fragment using A. caviae Sch3N genomic DNA as 
template. 
PCR was carried out using Q5 DNA polymerase and A. caviae Sch3N genomic 
DNA. 5 ul of the PCR products were observed following electrophoresis in a 1% 
agarose gel. Primers used to amplify these products are shown in Table 3.1. Lane 1, 
2-Log linear DNA ladder (Appendix 1); lane 2, flaA1 gene fragment (676bp); lane 3, 
flaB2 gene fragment (510bp). 
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  1      2 
   
Figure 3.4 Analysis of mini-preparation of the pKNG101::flaA::Km::flaB 
plasmid. 
Plasmid DNA product was carried out using mini-preparation of plasmid DNA 
following section 2.12 protocol. 5 ul of the plasmid DNA products were observed 
following electrophoresis in a 1% agarose gel. Lane 1, supercoiled DNA ladder 
(Appendix 1); lane 2, pKNG101::flaA::Km::flaB (9585bp). 
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(A)                    (B)      
1     2            1     2   3     4 
            
Figure 3.5 Analysis of PCR products following amplification of a DNA 
fragment containing the flaA and flaB genes using A. caviae Sch3N (WT) 
and A. caviae flaA::Km::flaB genomic DNA as template. 
PCR was carried out using Q5 DNA polymerase and A. caviae Sch3N genomic 
DNA and A. caviae Sch3N flaA::Km::flaB genomic DNA. 5 ul of the PCR products 
were observed following electrophoresis in a 1% agarose gel. Primers used to amplify 
these products were shown in Table 3.1.  
 
(A) Lane 1, 2-Log linear DNA ladder; lane 2, PCR product containing flaA1 gene and 
flaB2 gene from A. caviae Sch3N (WT) (~2500bp) using flaAISAF1 and flaBISAR2 as 
primers; 
 
(B) Lane 1, 2-Log linear DNA ladder; lane 2, PCR product containing flaA1 gene and 
flaB2 gene from A. caviae flaA::Km::flaB (~2600bp) using flaAISAF1 and flaBISAR2 
as primers; lane 3, PCR product containing flaA1 gene and flaB2 gene from A. caviae 
flaA::Km::flaB after restriction enzyme digestion with HindIII; lane 4, flaA1 gene and 
flaB2 gene from A. caviae Sch3N (WT) after restriction enzyme digestion with HindIII. 
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3.3 Construction of a series of flaA gene mutants 
In order to express various flagellin deletion derivatives in the A. caviae flaA-flaB 
mutant, primers were designed to result in a sequentially smaller flagellin encoding 
PCR fragment reducing from the 3’ end. The PCR’s all used the same forward primer, 
but different reverse primers that incorporated a new stop codon that would stop 
translation of the flagellin in each of the constructs. Giving rise to a series of flagellin 
that were sequentially 6 amino acids smaller than the previous construct. Both sets of 
primers incorporated with HindIII cutting site to help with cloning. 
 
Construction of pBBR1-MCS containing flaA gene deletion constructs was 
required in this project. A series of flaA gene fragments were cloned into pBBR-1MCS 
via restriction enzyme digestion and ligation. There are 17 primers designed in this 
project (Appendix 1) and 16 kinds of flaA gene fragments that were amplified via PCR 
(Figure 3.6). After digestion with HindIII and ligation, 32 kinds of pBBR1-MCS flaA 
gene insertion were created (Table 3.2). The flaA gene fragments were cloned into 
pBBR1-MCS in both orientations due to digestion of the plasmid with a single enzyme 
and both sets of constructs would be tested in the subsequent experiments. 
 
The flaA gene and flaA gene deletions which have the same orientation as the 
plasmid lacZα gene were labeled with ”-” and the flaA gene and flaA gene deletions 
which have the opposite orientation as lacZα gene were labeled with ”+”. There is a 
lac promoter at the upstream region of the multiple cloning site (MCS) which possibly 
regulates the expression of flaA gene and flaA gene deletions inserted in the 
“-“ orientation. 
 
The constructs reduced the A. caviae FlaA flagellin from its wild-type length of 
306 amino acids in construct FlaA0 to 220 amino acids in length in construct FlaA15 
(Figure 3.6 and Table 3.3). 
 
 
 
 
 
66 
 
(A)                                       (B) 
  1   2   3    4    5   6   7    8        1   2  3  4   5   6  7  8   9 
          
Figure 3.6 Analysis of PCR products following amplification of flaA gene 
fragment using pBBR1-MCS-flaA series plasmids (minus orientation) as 
template.  
PCR was carried out using Q5 DNA polymerase and pBBR1-MCS-flaA series 
plasmids (minus orientation). 5 ul of the PCR products were observed following 
electrophoresis in a 1% agarose gel. Primers used to amplify these products are M13 
forward primer and M13 reverse primer.  
 
(A) Lane 1, 2-Log linear DNA ladder; lane 2, flaA1- gene fragment (1187bp); lane 3, 
flaA2- gene fragment (1169bp); lane 4, flaA3- gene fragment (1151bp); lane 5, flaA4- 
gene fragment (1133bp); lane 6, flaA5- gene fragment (1115bp); lane 7, flaA6- gene 
fragment (1097bp); lane 8, flaA7- gene fragment (1079bp). lane 9, flaA8- gene 
fragment (1061bp). 
 
(B) Lane1, 2-Log linear DNA ladder; lane 2, flaA9- gene fragment (1043bp); lane 3, 
flaA10- gene fragment (1025bp); lane 4, flaA11- gene fragment (1007bp); lane 5, 
flaA12- gene fragment (989bp); lane 6, flaA13- gene fragment (971bp); lane 7, flaA14- 
gene fragment (953bp); lane 8, flaA15- gene fragment (935bp). 
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Table 3.2 pBBR1-MCS derivatives containing flaA fragments. 
flaA gene fragment Opposite to lacZα gene 
orientation 
Same as lacZα gene 
orientation 
flaA pBBR1-MCS-flaA0+ pBBR1-MCS-flaA0- 
flaA1 pBBR1-MCS-flaA1+ pBBR1-MCS-flaA1- 
flaA2 pBBR1-MCS-flaA2+ pBBR1-MCS-flaA2- 
flaA3 pBBR1-MCS-flaA3+ pBBR1-MCS-flaA3- 
flaA4 pBBR1-MCS-flaA4+ pBBR1-MCS-flaA4- 
flaA5 pBBR1-MCS-flaA5+ pBBR1-MCS-flaA5- 
flaA6 pBBR1-MCS-flaA6+ pBBR1-MCS-flaA6- 
flaA7 pBBR1-MCS-flaA7+ pBBR1-MCS-flaA7- 
flaA8 pBBR1-MCS-flaA8+ pBBR1-MCS-flaA8- 
flaA9 pBBR1-MCS-flaA9+ pBBR1-MCS-flaA9- 
flaA10 pBBR1-MCS-flaA10+ pBBR1-MCS-flaA10- 
flaA11 pBBR1-MCS-flaA11+ pBBR1-MCS-flaA11- 
flaA12 pBBR1-MCS-flaA12+ pBBR1-MCS-flaA12- 
flaA13 pBBR1-MCS-flaA13+ pBBR1-MCS-flaA13- 
flaA14 pBBR1-MCS-flaA14+ pBBR1-MCS-flaA14- 
flaA15 pBBR1-MCS-flaA15+ pBBR1-MCS-flaA15- 
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Figure 3.7 The amino acid number of each expressed FlaA deletion 
derivative from pBBR1-MCS-flaA series plasmids 
Starting with the N-terminal chain there are four domains including D0, D1, D2 
and D3, the C-terminal chain is back to D0 to form a coiled coil. FlaA and FlaA 
deletions are listed in order of decreasing size and the amino acid number of each 
FlaA and FlaA deletions are described too. The deletions sequentially remove the 
CD0 and CD1 domain components from the C-terminal end of the flagellin. 
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Table 3.3 The pBBR1-MCS-flaA series plasmids and components amino acid 
number of each expressed FlaA deletion. 
Name of plasmid Name of expressed protein  Number of amino 
acids 
pBBR1-MCS-flaA 0- FlaA 306 
pBBR1-MCS-flaA1- FlaA1- 304 
pBBR1-MCS-flaA2- FlaA2- 298 
pBBR1-MCS-flaA3- FlaA3- 292 
pBBR1-MCS-flaA4- FlaA4- 286 
pBBR1-MCS-flaA5- FlaA5- 280 
pBBR1-MCS-flaA6- FlaA6- 274 
pBBR1-MCS-flaA7- FlaA7- 268 
pBBR1-MCS-flaA8- FlaA8- 262 
pBBR1-MCS-flaA9- FlaA9- 256 
pBBR1-MCS-flaA10- FlaA10- 250 
pBBR1-MCS-flaA11- FlaA11- 244 
pBBR1-MCS-flaA12- FlaA12- 238 
pBBR1-MCS-flaA13- FlaA13- 232 
pBBR1-MCS-flaA14- FlaA14- 226 
pBBR1-MCS-flaA15- FlaA15- 220 
 
3.4 Swimming motility assay of A. caviae flaA-flaB 
mutant and complemented strains. 
Mutation of the fla locus genes have been shown to affect motility (Rabaan et al. 
2001). In order to determine the influence of the flaA constructs on swimming motility 
of A. caviae Sch3N, swimming motility assays were carried out with the A. caviae 
Sch3N wild-type (WT), the A. caviae flaA-flaB mutant and the mutant complemented 
with pBBR1-MCS-flaA series plasmids. 
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The A. caviae flaA-flaB mutant (pBBR1-MCS-flaA0-) strain was created via 
conjugation of the A. caviae flaA-flaB mutant and S17-1 λpir (pBBR1-MCS-flaA0-). 
The A. caviae flaA-flaB mutant (pBBR1-MCS-flaA0+) was created via conjugation of A. 
caviae flaA-flaB mutant and S17-1 λpir (pBBR1-MCS-flaA0+). The plasmids 
pBBR1-MCS-flaA0+ and pBBR1-MCS-flaA0- were transfered into the A. caviae 
flaA-flaB mutant to see if these plasmids can compensate the swimming ability of A. 
caviae flaA-flaB mutant and to determine if the presentation of the gene in the plasmid 
had any effect on the complementation assay. 
 
When tested for the ability to swim though semi-solid motility agar as expected 
the A. caviae flaA-flaB mutant strain was found to be non-motile compared to 
wild-type (WT) (Figure 3.8 and Figure 3.9). A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA0+) strain was found to be non-motile which means the motility 
deficiency of A. caviae flaA-flaB mutant was not compensated. The A. caviae flaA-flaB 
mutant (pBBR1-MCS-flaA0-) was found to be motile which means the motility 
deficiency of the A. caviae flaA-flaB mutant was compensated (Figure 3.8 and Figure 
3.9). Six motility plates were set up and three repeats were carried out (18 plates in 
total). Plasmids containing flaA1+~flaA15+ and flaA1-~flaA15- did not show the ability 
to compensate the motility deficiency of A. caviae flaA-flaB mutant (Data not shown). 
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(A)                                           (B) 
             
(C)                                           (D) 
          
(E)                                           (F) 
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Figure 3.8 Swimming motility assay of A. caviae Sch3N (WT), A. caviae 
flaA-flaB mutant and complemented strains 
Strains were incubated at room temperature for 16 hours. Motility was assessed by 
the production of a halo caused by bacterial migration.Strains of A. caviae Sch3N 
tested for motility on 0.25% motility agar. 
(A) shows A. caviae flaA-flaB mutant is non-motile on swimming motility agar. 
 
(B) shows A. caviae flaA-flaB mutant (pBBR1-MCS-flaA0-) is motile on swimming 
motility agar. 
 
(C) shows A. caviae flaA-flaB mutant (pBBR1-MCS-flaA0+) is non-motile on 
swimming motility agar. 
 
(D) shows A. caviae flaA-flaB mutant (pBBR1-MCS-flaA1-) is non-motile on swimming 
motility agar.  
 
(E) shows A. caviae flaA-flaB mutant (pBBR1-MCS-flaA1+) is non-motile on 
swimming motility agar.  
 
(F) shows A. caviae Sch3N (WT) is motile on swimming motility agar. 
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Figure 3.9 Quantification of the swimming assays of A. caviae Sch3N (WT) 
and mutant strains.  
The swimming diameter of each strain was measured on the swimming agar after 
overnight incubation at 37°C. The swimming diameters were significantly lower in the 
flaA-flaB mutant when compared to the A. caviae Sch3N wild type (p<0.001). The 
swimming diameters of A. caviae flaA-flaB mutant (pBBR1-MCS-flaA0+) was 
considerably greater than the untransformed mutant, thereby demonstrating 
complementation. A. caviae flaA-flaB mutant (pBBR1-MCS-flaA1-) and A. caviae 
flaA-flaB mutant (pBBR1-MCS-flaA1+) were significantly decreased when compared 
to the A. caviae Sch3N wild type (p<0.001). The swimming diameters were measured 
3 times for each strain. The error bars showed Standard Error of the Mean (SEM). 
The significance was determined using Student’s t-test. 
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3.5 Western blotting of FlaA deletion derivatives in 
complemented strains 
In order to determine how much of the C-terminal section of the flagellin is 
required for glycosylation and to begin to determine where Maf1 binds flagellin 
western blot analysis was performed to see if the deletion constructs were still able to 
be glycosylated. 
 
In order to test the functions of FlaA deletion derivatives in glycosylation in the A. 
caviae Sch3N, protein expressions of the flaA gene deletions were attempted. 
Plasmids containing modified flaA genes have been constructed and transferred into 
A. caviae flaA-flaB mutant. The construct pBBR1-MCS-flaA0- has been shown to be 
able to to compensate the motility deficiency of A. caviae flaA-flaB mutant and this 
finding suggests the plasmids containing flaA0-~flaA15- are functional in the A. caviae 
flaA-flaB mutant and these conjugated strains are all capable of expressing FlaA. 
Based on that, all these 16 plasmids were selected to be conjugated with A. caviae 
flaA-flaB mutant and tested by Western blotting. Each conjugated strain will express a 
particular modified FlaA protein which is missing a small part of amino acid sequence 
at its C-terminal. There are 2 antibodies applied in this experiment, anti-polar flagellin 
antibody is designed to recognize glycosylated FlaA and anti-FlaA antibody is 
designed to recognize total FlaA, glycosylated or unglycosylated. 
 
The wild-type, mutant and complemented mutant strains were grown in broth 
overnight at 37°C, the OD of each culture was normalised and the load sample 
harvested by centrifugation. The pellet was boiled in SDS-PAGE sample buffer and 
then the proteins were separated by 12% SDS-PAGE and blotted onto nitrocellulose 
membrane. The membrane was then probed with the rabbit anti-polar flagellin 
antibody that only recognises the glycosylated version of the Aeromonas polar 
flagellin. The polar flagellins are present in the wild-type sample but absent in the 
mutant as expected (Figure 3.10). The glycosylated flagellin is detected in the mutant 
expressing FlaA0- at the same size as the wild type (Figure 3.10). The FlaA deletion 
derivatives expressed by pBBR1-MCS-flaA1- to pBBR1-MCS-flaA15- were partially 
detected by anti-polar flagellin antibody. There were only 5 samples including FlaA15, 
FlaA13, FlaA11, FlaA9 and FlaA 7 detected (Figure 3.10). The FlaA deletion 
derivatives expressed by pBBR1-MCS-flaA10-~ pBBR1-MCS-flaA15- were probed 
with the Anti-FlaA antibody to confirm the expressions of these proteins and part of 
these proteins were detected by Anti-FlaA antibody (Figure 3.11).  
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The cultures of A. caviae flaA-flaB mutant (pBBR1-MCS-flaA8-) and A. caviae 
flaA-flaB mutant (pBBR1-MCS-flaA9-) were sonicated and separated into insoluble 
fraction and soluble fraction to determine the solubility of FlaA8- expressed by 
pBBR1-flaA8- and FlaA9- expressed by pBBR1-MCS-flaA9- (Figure 3.12). 
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   1    2    3     4     5     6    7    8    9   10   11   12 
 
(B) 
   1     2    3    4     5     6    7     8       9 
 
Figure 3.10 Analysis of FlaA and FlaA deletion derivatives from A. caviae 
strains. 
All strains were grown in BHIB at 37°C for overnight. 20 µl of total proteins from 
each strain were electrophoresed in a 12% SDS polyacrylamide gel. The gel was 
applied to be analysed by Western Blot following section 2.22 protocol and flagellins 
(~35Da) from A. caviae strains were selected via rabbit anti-polar flagellin antibody 
and anti-rabbit HRP. The flagellin FlaA in the mutant background was observed to be 
sequentially smaller in size from FlaA1 to FlaA9 after which the glycosylated Flagellin 
is not detected. 
(A) lane 1, A. caviae Sch3N wild-type (WT); lane 2, A. caviae flaA-flaB mutant; lane 3, 
A. caviae flaA-flaB mutant (pBBR1-MCS-flaA0-); lane 4, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA1-); lane 5, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA2-); lane 6, 
A. caviae flaA-flaB mutant (pBBR1-MCS-flaA3-); lane 7, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA4-); lane 8, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA5-); lane 9, 
A. caviae flaA-flaB mutant (pBBR1-MCS-flaA6-); lane 10, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA7-); lane 11, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA8-); lane 
12, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA9-) 
 
(B) lane 1, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA8-); lane 2, A. caviae flaA-flaB 
mutant (pBBR1-MCS-flaA9-); lane 3, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA10-); lane 4, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA11-); lane 
5, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA12-); lane 6, A. caviae flaA-flaB 
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mutant (pBBR1-MCS-flaA13-); lane 7, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA14-); lane 8, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA15-); lane 
9, A. caviae Sch3N wild-type (WT). 
 
1      2     3    4      5    6     7     8       9    10   11 
 
Figure 3.11 Analysis of FlaA and FlaA deletion derivatives from A. caviae 
strains. 
All strains were grown in BHIB at 37°C for overnight. 20 ul of total proteins from 
each strain were electrophoresed in a 12% SDS polyacrylamide gel. The gel was 
applied to be analysed by Western Blot following section 2.22 protocol and flagellins 
(~35Da) from A. caviae strains were selected via rat anti-FlaA antibody and 
anti-mouse HRP. The flagellin FlaA in the mutant background to be observed to 
sequentially get large in size from FlaA15 to FlaA7. Lane 1, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA15-); lane 2, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA14-); 
Lane 3, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA13-); Lane 4, A. caviae flaA-flaB 
mutant (pBBR1-MCS -flaA12-); lane 5, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA11-); lane 6, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA10-); lane 
7, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA9-); lane 8, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA8-); lane 9, A. caviae flaA-flaB mutant (pBBR1-MCS-flaA7-); lane 
10, A. caviae flaA-flaB mutant; lane 11, A. caviae Sch3N wild-type (WT). 
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       1       2       3       4 
 
Figure 3.12 Analysis of FlaA deletion derivatives from A. caviae strains. 
FlaA8- and FlaA9- were expressed from pBBR1-MCS-flaA8- and 
pBBR1-MCS-flaA9- in A. caviae flaA-flaB mutant background. Cells were grown in LB 
broth at 37°C with 1mM IPTG addition for 3 hours. Cells were disrupted by sonication 
and separated into soluble and insoluble fractions (supernatant and pellet) by 
centrifugation. 20 ul of total proteins from each strain were electrophoresed in a 12% 
SDS polyacrylamide gel. The gel was applied to be analysed by Western Blot 
following section 2.22 protocol and flagellins (~35Da) from A. caviae strains were 
selected via rabbit anti-polar flagellin antibody and anti-rabbit HRP. Lane 1, A. caviae 
flaA-flaB mutant (pBBR1-MCS-flaA8-) (insoluble fraction); Lane 2, A. caviae flaA-flaB 
mutant (pBBR1-MCS-flaA9-) (insoluble fraction); Lane 3, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA8-) (soluble fraction); Lane 4, A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA9-) (soluble fraction). 
 
3.6 Discussion 
The fla locus of A. caviae Sch3N is linked to the biosynthesis of polar flagella 
filament. This locus includes flaA, flaB, flaG, flaH and flaJ which have been listed in 
genetic order (Rabaan et al. 2001). 
 
The flaA and flaB of A. caviae Sch3N encode two flagellin subunits. Strain that 
lacks flaA and flaB shows no motility and further study proved that production of 
flagellins in this strain is absolutely terminated (Rabaan et al. 2001). Motility and 
adherence drop to about 50% in the strain with single mutation in flaA or flaB in which 
flagella are still expressed. This finding indicates that flaA-flaB compose flagellin with 
a 1:1 ratio (Rabaan et al. 2001). 
 
In this project, A. caviae flaA-flaB mutant was constructed. This mutant shows no 
motility therefore, it agrees with the findings of Rabaan et al (2001) and it is suitable 
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for the investigation of flaA. 
 
Expression of the complete flaA gene (flaA0) in the minus orientation resulted in 
complementation, whereas in the plus orientation it did not, this suggests expression 
of the flagellin is better or greater in the minus orientation. The possible reason for this 
result is the regulation of lac promoter. 
 
Based on the result from this project, pBBR1-MCS-flaA0- can partially restore the 
swimming ability of A. caviae flaA-laB mutant and pBBR1-MCS-flaA0+ can not restore 
the swimming ability of A. caviae flaA-flaB mutant. Besides, pBBR1-MCS-flaA1+~ 
pBBR1-MCS-flaA15+ are all failure to restore the swimming ability of A. caviae 
flaA-flaB mutant and the same result was observed from 
pBBR1-MCS-flaA1-~pBBR1MCS-flaA15-. This finding indicates that 
pBBR1-MCS-flaA0+~pBBR1MCS-flaA15+ are not functional in the conjugated strains 
and pBBR1-MCS-flaA0-~pBBR1-MCS-flaA15- are all functional and producing FlaA 
or modified FlaA in the conjugated strains. The failure to restore the swimming ability 
for pBBR1-MCS-flaA1-~pBBR1-MCS-flaA15- is probably caused by the deletion of 
chaperone binding domain of FlaA (parker 2014). The deletion of chaperone binding 
domain of FlaA leads to the failure of binding of FlaJ and result in the failure of export 
of flagellin. 
 
For the next step, the strains including A. caviae flaA-flaB mutant 
(pBBR1-MCS-flaA1-) to A. caviae flaA-flaB mutant (pBBR1-MCS-flaA15-) are all 
selected for Western Blotting of flagellin detection. According to the Western Blotting 
results, the FlaA deletion expressed by pBBR1-MCS-flaA8- was glycosylated and 
FlaA deletion expressed by pBBR1-MCS-flaA10- was unglycosylated.  
 
The N and C-terminal D0 and D1 domains of bacterial flagellins are usually 
essential for the chaperone binding, export and polymerization and these domains are 
usually conserved(Auvray et al. 2001). It has been proved that the FlaA without the 
C-terminal chaperone-binding domain (CBD amino acids 261–306) still can be 
glycosylated but it is unable to bind FlaJ in A. caviae which means the chaperone 
binding domain of FlaA is not required for glycosylation of flagellin (Parker et al. 2014). 
In this experiment, the amino acids 220–306 from C-terminal chaperone-binding 
domain were sequentially deleted to determine the function of these amino acids. 
Based on the result of Western Blotting in section 3.15, it has been confirmed that 
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FlaA which lacks the CBD amino acids 220-250 can not be glycosylated and FlaA 
which lacks the CBD amino acids 256-306 can be glycosylated. This result suggested 
that the Site of Maf bind is required is around amino acids 256-250. Further 
experiment will be applied to determine if Maf1 can bind these FlaA deletion 
derivatives. Wether the FlaA deletion derivatives which lack the CBD amino acids 
256-306 can bind the Maf1 will be investigated in the future. 
 
With the help of Anti-FlaA antibody, FlaA deletions expressed by 
pBBR1-MCS-flaA7- to pBBR1-MCS-flaA15- have been partially detected and this 
finding confirmed that the flagellins after deletion of CBD amino acids 220-250 were 
still expressed but unglycosylated. However, FlaA14-, FlaA12- and FlaA10- were not 
detected by anti-FlaA antibody and the reason for that may be the samples were not 
prepared properly or the plasmids did not express well. It can be observed form figure 
3.11 that the bands are getting shallow from FlaA to FlaA15- which indicates that the 
abilities of binding anti-FlaA antibody of FlaA deletion derivatives are reducing. The 
explanation for this result may be the loss of C-terminal amino acids. 
 
In order to reconstruct the glycosylation of FlaA in vitro, a source of soluble FlaA 
deletion derivative which still can be glycosylated is required. The FlaA8- expressed 
by pBBR1-MCS-flaA8- and FlaA9- expressed by pBBR1-MCS-flaA9- have been 
tested and the result indicates that the FlaA8- and FlaA9- were both detected in the 
soluble fractions. This finding suggests that FlaA8- and FlaA9- are soluble and 
glycosylated which are suitable for the further experiments. 
 
3.7 Conclusion 
However, expression of FlaA0- only resulted in partial (50%) recovery of motility 
in the mutant strain, this is in agreement with Rabaan et al 2001 that created better 
single mutant in both flaA gene and flaB gene instead of double mutant in flaA gene 
and flaB gene. This suggests that both flagellins are required for optimal flagella 
filament function. Or that the expression leads of the flagellins are not optimal. 
However, on comparation with the normal western blot the flagellin levels of the flaA0- 
expressing strain do not look great selected compared to the wild type (Figure 3.7). 
 
The plasmids including pBBR1-MCS-flaA0+~pBBR1-MCS-flaA15+ and 
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pBBR1-MCS-flaA0-~pBBR1-MCS-flaA15- are all functional and producing FlaA or 
modified FlaA in the conjugated strains. pBBR1-MCS-flaA0- can produce fully 
functional FlaA and partialy restore the swimming ability of A. caviae flaA-flaB mutant. 
pBBR1-MCS-flaA0+ can not restore the swimming ability of A. caviae flaA-flaB mutant 
(Figure 3.8). The rest of all plasmids with flaA gene deletion can not restore the 
swimming ability of A. caviae flaA-flaB mutant. This result indicates that complete 
FlaA encoded by pBBR1-MCS-flaA0- is essential for the flagella assembly and 
deletion in flaA gene will result in absence of functional flagella.  
 
Deletion strains including A. caviae flaA-laB mutant (pBBR1-MCS-flaA1-) ~A. 
caviae flaA-flaB mutant (pBBR1-MCS-flaA15-) are non-motile. This result is probably 
caused by not bound correctly by FlaJ (CBD removed) (Parker et al. 2012). Western 
Blotting of these FlaA deletions shows that FlaA0- to FlaA9- were all glycosylated and 
FlaA10- to FlaA15- were all unglycosylated (Figure 3.10 and Figure 3.11). This result 
suggested that the Site of Maf bind is required is around amino acids 256-250. The 
flagellins after deletion of CBD amino acids 220-250 were still expressed but 
unglycosylated and FlaA10- to FlaA15 did not decomposed. The FlaA8- expressed by 
pBBR1-MCS-flaA8- and FlaA9- expressed by pBBR1-MCS-flaA9- have been tested 
and the result indicates that the FlaA8- and FlaA9- were both detected in the soluble 
fractions (Figure 3.12). This finding suggests that FlaA8- and FlaA9- are soluble and 
glycosylated which are suitable for the further experiments. 
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Chapter 4 Investigation of pseudaminic acid 
biosynthesis in Aeromonas caviae 
4.1 Introduction 
Recently, a flm locus of A. caviae Sch3N was identified. This locus which includes 
flm genes consists of flmA(PseB), flmB(PseC), neuA(PseF), flmD(PseG/H), and 
neuB(PseI). Following the flm locus, there are lsg and lst which encode the LPS 
O-antigen flippase and transferase respectively (Tabei et al. 2009). In A. caviae 
Sch3N, the flm locus is involved in both flagellin glycosylation and lipopolysaccharide 
(LPS) O-antigen(O-Ag) biosynthesis, the mutants without these genes lost motility, 
flagella, and their LPS O-antigen (Gryllos et al. 2001). 
 
Based on the papers published before, LPS O-antigen biosynthesis and flagellin 
glycosylation can be cross correlated. In A. caviae Sch3N, the flagellin is 
O-glycosylated with Pse5Ac7Ac while the LPS contains the same sugar (Tabei et al. 
2009; Parker et al. 2012). Based on the two mechanisms summarized above, it is 
clear that Pse5Ac7Ac acts as a pivotal factor which connects the two mechanisms 
with glycosylation. Because of that, the investigation of the proteins involved in 
Pse5Ac7Ac biosynthetic pathway becomes very valuable. NeuA which directly 
interacts with Pse5Ac7Ac is a crucial target that has been applied in this project. 
 
LPS is consists of a lipid portion, a core oligosaccharide (OS) and an O-specific 
polysaccharide which is known as the O-antigen (Nikaido 1996; Whitfield and Valvano 
1993). The surface-exposed LPS O-antigen which is required for virulence in many 
pathogenic bacteria prevents the cell from elimination by immune system (Tomás 
2012). 
 
The genes and proteins for the synthesis of Pse5Ac7Ac have been studied in the 
pathogen C. jejuni and H. pylori and the biosynthetic pathway has been elucidated 
and in order to investigate the Pse5Ac7Ac glycosylation of the Aeromas flagellin 
further, a source of CMP-Pse5Ac7Ac was needed. Therefore, attempts to reconstruct 
the biosynthetic pathway were undertaken. 
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4.2 Construction of A. caviae flmA mutant and A. 
caviae neuA mutant 
NeuA of A. caviae which is CMP-sugar synthetase is an important target of this 
project and the function of this protein has been investigated via the homologous 
proteins in other bacteria. In order to determine the role of neuA in A. caviae, a mutant 
strain that lacks neuA was constructed in this project. As the previous mutant made in 
the lab was shown to be polar and effect the expression of downstream genes. 
 
Furthermore, we wished to see the effect of an N-terminal His-tag on the function 
of the enzyme in A. caviae. As a previous attempt to over-express the NeuA protein in 
E. coli had resulted in an insoluble protein. Therefore, an alternative approach to 
express His-containing NeuA in A. caviae was considered. 
 
In order to create this mutant, 2 DNA fragments, neuA1 and neuA2, were 
designed and obtained by PCR first and these DNA fragments represented the 5’ and 
3’ portions of neuA respectively (Figure 4.2A). Then the Km cassette which is a PCR 
amplified Tn5-derived kanamycin resistance cartridge (nptII)) and pKNG101 digested 
with BamHI were prepared. The DNA fragments and plasmid used in ISA are listed in 
Table 4.1. The concentrations of all DNA samples were measured using nanodrop. 
After that, ISA was applied and the reaction mix was transformed into E. coli 
CC118λpir to be selected (SmR and KmR). Resistant colonies were isolated and the 
possible recombinant vectors were analysed by PCR screening (section 2.7.4). Then 
the selected pKNG101::neuA::Km construct (Figure 4.3) was confirmed by DNA 
sequencing and retransformed into E. coli S17-1 λpir for the conjugation with A. 
caviae Sch3N (NalR) (Figure 4.3). The strains obtained from conjugation were grown 
on two TSA plates. One TSA plate contains kanamycin and nalidixic acid, the other 
plate contains kanamycin and streptomycin. Strains that were kanamycin resistant but 
streptomycin sensitive, were thought to have undergone allelic exchange through a 
double homologous recombination event. Those strains were subsequently checked 
by a diagnostic PCR to confirm the result (Figure 4.4). This resulted in the neuA 
mutant strain A. caviae Sch3N neuA::Km. 
 
The function of flmA was also been looked into. The strain A. caviae Sch3N 
flmA::Km was constructed in this project via a similar way. 2 DNA fragments, flmA1 
and flmA2, were designed and obtained by PCR and these DNA fragments 
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represented the 5’ and 3’ portions of flmA respectively (Figure 4.1). Then the strain A. 
caviae Sch3N flmA::Km was created in a similar way as above strain A. caviae Sch3N 
neuA::Km.  
 
Table 4.1 DNA fragments and plasmid used in ISA and primers of neuA1 and 
neuA2. Complementary termini of 40bp sequence homology were added to 
the original Km cassette, neuA1 and neuA2 genes. 
Names Sizes 
(bp) 
Primers 
neuA1 345+40bp NeuAISAF1: 5’CCCCTGCAGGTCGACGGATCAATATTGCCATCATCCCTGC 
NeuAISAR1: 5’ACATGAGGACCAAGGAGAATATCATCAGGCTCAACAAAAGGT 
neuA2 328+40bp NeuAISAF1:5’AGTACCTAGCCAAGGTGTGCTGCCAGGGATTAGAATTGTTAACGT 
NeuAISAR2: 5’ACTTATGGTACCCGGGGATCGCGTAAATAGCTTCTCAGCAC 
flmA1 539bp FlmA-ISA1-F:5’ CCCCCCCCCTGCAGGTCGACGGATCATTAATCACAGGTGGTACGGG 
FlmA-ISA1-R:5’ GTCAAACATGAGAACCAAGGAGAATCCATAGCGAACTACACTGAATC 
flmA2 553bp FlmA-ISA2-F:5’ GTTTTAGTACCTAGCCAAGGTGTGCAATGTAATGGGGTCTCGGG 
FlmA-ISA2-R:5’ CTTCTACTTATGGTACCCGGGGATTCACACTTCAAAGTTGGCATCT 
Km cassette 1452+40bp Kmfor: 5’ TTCTCCTTGGTTCTCATGTTTGACAGCTT 
Kmrev: 5’ GCACACCTTGGCTAGGTACTAAAACAATTC 
pKNG101 6986bp N/A 
pKNG101::neuA::Km 9115bp N/A 
pKNG101::flmA::Km 9434bp N/A 
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(A) 
  
(B)  
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(C) 
 
(D) 
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Figure 4.1 Isothermal assembly (ISA) method for constructions of 
pKNG101::neuA::Km and pKNG101::flmA::Km and constructions of A. 
caviae neuA::Km and of A. caviae flmA::Km. 
. 
(A) This plasmid was constructed using Isothermal assembly of the 385bp 5’ neuA 
fragment the 1452+40bp Km cassette, and the 368bp 3’ neuA fragment assemble into 
BamHI digested pKNG101. Arrows show the direction of selected open reading 
frames and the sites of primers are induced. The PCR fragments neuA1 and neuA2 
were generated with primers that had overhangs with the pKNG101 and kanamycin 
cassette (neuA1) and the kanamycin cassette and pKNG101 (neuA2) respectively. 
The four DNA fragments neuA1, Km, neuA2 and pKNG101 were mixed together at 
equimolar concentrations and assembled together using ISA. 
 
(B) A diagrammatic representation of allelic exchange between the suicide vector 
construct pKNG101::neuA::Km and the neuA gene on the chromosome of A. caviae 
Sch3N following conjugation of suicide plasmid from E. coli S17-1-λpir into the 
Aeromonas cells. Potential double crossover mutants were selected by replica plating. 
Each colony was patched on to two LB agar plates, one with kanamycin and nalidixic 
acid and the other one with kanamycin and streptomycin. Those that were 
streptomycin sensitive were taken for further investigation. The features of the 
plasmid vector were shown in arrows. The neuA gene was shown in purple arrow and 
the KmR cassette was shown in grey arrow. The figure was created using 
SnapGene®software 
 
(C)This plasmid was constructed using Isothermal assembly of the 539bp 5’ flmA 
fragment, the 1452+40bp Km cassette, and the 553bp 3’ flmA fragment to be 
assembled into BamHI digested pKNG101. Arrows show the direction of selected 
open reading frames and the sites of primers are induced. The PCR fragments flmA1 
and flmA2 were generated with primers that had overhangs with the pKNG101 and 
Km cassette (flmA1) and the Km cassette and pKNG101 (flmA2) respectively. The 
four DNA fragments flmA1, Km cassette, flmA2 and pKNG101 were mixed together at 
equimolar concentrations and assembled together using ISA. 
 
(D) A diagrammatic representation of allelic exchange between the suicide vector 
construct pKNG101::flmA::Km and the flmA gene on the chromosome of A. caviae 
Sch3N following conjugation of suicide plasmid from E. coli S17-1-λpir into the 
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Aeromonas cells. Potential double crossover mutants were selected by replica plating. 
Each colony was patched on to two LB agar plates, one with kanamycin and nalidixic 
acid and the other one with kanamycin and streptomycin. Those that were 
streptomycin sensitive were taken for further investigation. The features of the 
plasmid vector were shown in arrows. The flmA gene was shown in purple arrow and 
the KmR cassette was shown in grey arrow. The figure was created using 
SnapGene®software. 
 
(A)                           (B)   
      1     2     3            1     2     3 
       
Figure 4.2 Analysis of PCR products following amplification of (A) neuA 
gene fragment 1 and neuA gene fragment 2, (B) flmA gene fragment 1 
and flmA gene fragment 2 using A. caviae Sch3N genomic DNA as 
template. 
PCR was carried out using Pfx DNA polymerase and A. caviae Sch3N genomic 
DNA. 5 ul of the PCR products were observed following electrophoresis in a 1% 
agarose gel. Primers used to amplify these products are shown in Table 3.1. (A) 
Lane1, Q-step4 linear DNA ladder; lane 2, neuA gene fragment 1 (~380bp); lane 3, 
neuA gene fragment 2 (~360bp); (B) Lane1, Q-step4 linear DNA ladder; lane 2, flmA 
gene fragment 1 (539bp); lane 3, flmA gene fragment 2 (553bp). 
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(A)                   (B) 
     1        2            1        2 
       
Figure 4.3 Analysis of mini-preparation of the pKNG101::neuA::Km and 
pKNG101::flmA::Km plasmids. 
Plasmid DNA product was purified using the mini-preparation protocol (section 
2.12). 5 ul of the plasmid DNA products were observed following electrophoresis in a 
1% agarose gel. (A) Lane1, supercoiled DNA ladder; lane 2, pKNG101::neuA::Km; (B) 
Lane1, supercoiled DNA ladder; lane 2, pKNG101::flmA::Km. 
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(A)                     (B) 
    1     2    3          1    2 
         
Figure 4.4 Analysis of (A) neuA gene from A. caviae Sch3N (WT) and A. 
caviae neuA::Km strain, (B) flmA gene from A.caviae flmA::Km strain. 
PCR was carried out using Taq DNA polymerase and A. caviae Sch3N (WT) 
genomic DNA and A. caviae Sch3N neuA::Km genomic DNA. 5 ul of the PCR 
products were observed following electrophoresis in a 1% agarose gel. Primers used 
to amplify these products are shown in Table 3.1. (A) Lane1, 2-Log linear DNA ladder; 
lane 2, neuA gene from A. caviae neuA::Km strain (~2000bp); lane 3, neuA gene from 
A. caviae Sch3N (WT) (~700bp); (B) Lane1, 2-Log linear DNA ladder; lane 2, flmA 
gene from A. caviae flmA::Km strain (~2500bp) . 
4.3 Swimming motility assay of A. caviae neuA mutant 
and A. caviae flmA mutant 
Mutation of the flm locus genes have been shown to affect motility and the LPS of 
A. caviae (Gryllos et al. 2001). In order to determine the influence of neuA on 
swimming motility of A. caviae Sch3N, swimming motility assays were carried out with 
the A. caviae Sch3N wild-type (WT), the A. caviae neuA mutant and the previously 
constructed complementary strains A. caviae neuA mutant (pBBR1-MCS-neuA) and 
A. caviae neuA mutant (pBBR1-MCS-neuA-His). The plasmid pBBR1-MCS-neuA-His 
indicates that the neuA gene was attached with a polyhistidine-tag at the N-terminal. A. 
caviae neuA mutant (pBBR1-MCS-neuA) was created via conjugation of A. caviae 
neuA mutant and S17-1 λpir (pBBR1-MCS-neuA). A. caviae neuA mutant 
(pBBR1-MCS-neuA-His) was created via conjugation of A. caviae neuA mutant and 
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S17-1 λpir (pBBR1-MCS-neuA-His). The plasmids including pBBR1-MCS-neuA and 
pBBR1-MCS-neuA-His were provided by former researcher and they were 
conjugated with the A. caviae neuA mutant to see if these plasmids can compensate 
the swimming ability of A. caviae neuA mutant. Four motility plates were set up and 
three repeats were carried out (12 plates in total).  
 
The A. caviae neuA strain was found to be non-motile compared to wild-type 
(WT). A. caviae neuA mutant (pBBR1-MCS-neuA) strain was found to be motile which 
means the motility deficiency of A. caviae neuA mutant was compensated. The A. 
caviae neuA mutant (pBBR1-MCS-neuA-His) was found to be motile which means the 
motility deficiency of A. caviae neuA mutant was compensated (Figure 4.5). 
Furthermore, the addition of the N-terminal His-tag to NeuA did not affect the 
functionality of the enzyme. 
 
In order to determine the influence of flmA on swimming motility of A. caviae 
Sch3N, swimming motility assays were carried out with the A. caviae Sch3N wild-type 
(WT), the A. caviae flmA mutant. The A. caviae flmA mutant strain was found to be 
non-motile compared to wild-type (WT) (Figure 4.5 and Figure 4.6).  
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(A)                                    (B) 
      
(C)                                (D) 
          
(E)                             
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Figure 4.5 Swimming motility assay of A. caviae Sch3N (WT), A. caviae 
flmA mutant, A. caviae neuA mutant and complemented strains.  
Strains were incubated at room temperature for 16 hours. Motility was assessed 
by the production of a halo caused by bacterial migration. Strains of A. caviae Sch3N 
tested for motility on 0.25% motility agar.  
 
(A) Shows A. caviae neuA::Km is non-motile on swimming motility agar. Figure  
 
(B) Shows A. caviae neuA::Km (pBBR-neuA) is motile on swimming motility agar.  
 
(C) Shows A. caviae neuA::Km (pBBR-neuA-His) is motile on swimming motility agar.  
 
(D) Shows A. caviae Sch3N (WT) is motile on swimming motility agar.  
 
(E) Shows A. caviae flmA::Km is non-motile on swimming motility agar. 
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Figure 4.6 Quantification of the swimming assays of A. caviae Sch3N (WT) 
and mutant strains.  
The swimming diameter of each strain was measured on the swimming agar after 
overnight incubation at 37°C. The swimming diameters were significantly lower in the 
neuA mutant when compared to the A. caviae Sch3N wild type (p<0.001), while there 
was no significant difference of swimming diameter among the A. caviae neuA::Km 
(pBBR1-MCS-neuA) strain, A. caviae neuA::Km (pBBR1-MCS-neuA-His) strain and A. 
caviae Sch3N wild type strain (p>0.05). The swimming diameters of A. caviae flmA 
mutant was significantly decreased when compared to the A. caviae Sch3N wild type 
(p<0.001). The swimming diameters were measured 3 times for each strain. The error 
bars showed Standard Error of the Mean (SEM). The significance was determined 
using Student’s t-test. 
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4.4 LPS analysis and flagellin analysis of A. caviae 
Sch3N neuA::Km 
As previously shown, mutation of the flm locus affects the LPS of A. caviae (Tabei 
et al. 2009; Gryllos et al. 2001). LPS of the wild-type, mutant strain A. caviae Sch3N 
neuA::Km and complemented strains were investigated. In order to determine the role 
of neuA in LPS biosynthesis of A. caviae Sch3N, LPS extraction was applied in this 
project. The products of LPS extraction of A. caviae Sch3N wild-type (WT), A. caviae 
neuA mutant (pBBR1-MCS-neuA), A. caviae neuA mutant (pBBR1-MCS-neuA-His) 
and A. caviae neuA mutant were loaded and subjected to SDS-PAGE. The gel was 
then silver stained (Figure 4.7). The wild-type strain and the complemented strains 
possess both the A and B bands as previously described by Gryllos et al (2001) and 
Tabei et al (2009). Band B that represents the core plus O-antigen is missing from the 
A. caviae neuA mutant strain. 
 
To confirm the lack of motility phenotype observed for the mutant strain, the 
strains were probed for the production of flagellin protein, the whole-cell proteins of 
these mutants and wild-type were separated by SDS-PAGE. Then western blot was 
applied with rabbit anti-polar flagellin antibody and anti-rabbit HRP conjugate antibody. 
Figure 4.8 of Western bolt showed polar flagellins were absent in A. caviae neuA 
mutant and polar flagellin was present in the A. caviae Sch3N wild-type (WT), A. 
caviae neuA mutant (pBBR1-MCS-neuA) and A. caviae neuA mutant 
(pBBR1-MCS-neuA-His) strains (Figure 4.7). 
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Figure 4.7 Analysis of LPS extracted from WT and neuA mutant A. caviae 
strains. 
LPS was extracted from A. caviae Sch3N wild-type (WT), A. caviae neuA mutant, 
A. caviae neuA mutant (pBBR1-MCS-neuA) and A. caviae neuA mutant 
(pBBR1-MCS-neuA-His) and analysed by SDS-PAGE (12%) and silver stained 
according to section 2.17 and 2.18 protocols. Cells were grown in BHIB at 37°C for 
overnight. Lane 1, LPS from A. caviae Sch3N wild-type (WT); Lane 2, LPS from A. 
caviae neuA mutant; Lane 3, LPS from A. caviae neuA mutant (pBBR1-MCS-neuA); 
lane 4, LPS from A. caviae neuA mutant (pBBR1-MCS-neuA-His). 
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Figure 4.8 Analysis of flagellins from WT and neuA mutant A. caviae 
strains. 
Whole-cell protein prepared from A. caviae Sch3N wild-type (WT), A. caviae 
neuA mutant, A. caviae neuA mutant (pBBR1-MCS-neuA) and A. caviae neuA mutant 
(pBBR1-MCS-neuA-His). All strains were grown in BHIB at 37°C for overnight. 20 ul of 
total proteins from each strain were electrophoresed in a 12% SDS polyacrylamide 
gel and then blotted onto nitrocellulose membrane. The gel was applied to be 
analysed by Western Blot following section 2.22 protocol and polar flagellins (~35Da) 
from A. caviae strains were selected via rabbit anti-polar flagellin antibody and 
anti-rabbit HRP. Lane 1, Prestained protein ladder (sizes shown in kDa); Lane 2 polar 
flagellins from A. caviae Sch3N wild-type (WT); Lane 3, polar flagellins from A. caviae 
neuA mutant; Lane 4, polar flagellins from A. caviae neuA mutant 
(pBBR1-MCS-neuA); Lane 5, polar flagellins from A. caviae neuA mutant 
(pBBR1-MCS-neuA-His). 
 
4.5 Protein overexpression of flm genes 
Part of this project was to try and biochemically reconstitute the flagellin 
glycosylation process using pure A. caviae flagellin, the glycosyltransferase Maf1 and 
CMP-Pse5Ac7Ac. Therefore, a source of CMP-Pse5Ac7Ac is required. Previous 
workers have shown that this is possible using the equivalent Pse/Flm enzymes of H. 
pylori (Schoenhofen et al. 2006). 
 
In order to investigate pseudaminic acid biosynthetic pathway in A. caviae Sch3N, 
protein expression of the flm genes was attempted. Plasmids containing part modified 
flm genes were constructed in our laboratory and each flm gene when expressed 
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would produce a protein with N-terminal His6-tag. Due to solubility problems with 
FlmD proteins, flmD was cloned into pMAL-c5X in order to produce a protein with 
N-terminal MBP-tag. Both of the pET-28a-flmD which was constructed before and 
pMAL-c5X were digested with NdeI and BamHI then the products of two digestions 
were mixed together and ligated with ligase. After ligation, ampicillin resistant colonies 
were screened by colony PCR screen using pMAL screening primers with Taq DNA 
polymerase. Selected pMAL-c5X-flmD plasmid vector was then sequenced using 
pMAL screening primers to ensure the in-frame insertion, the orientation of the inserts 
and no mutation in the inserts. After examination with sequencing and BLAST search, 
pMAL-c5X-flmD plasmid was then transformed into E. coli (NEB Express) for the 
over-expression of the MBP-fused FlmD protein. 
 
The primers used to amplify flmA, flmB, neuA and neuB introduced an Nde1 
restriction site and a HindIII restriction site and a stop codon at either end of each 
gene allowing in-frame cloning into the pET-28a vector to ensure an N-terminal 
His-tag. The PCR products of the flm genes were then digested by Ndel and HindIII 
and ligated with the pET-28a plasmids digested by the same pair of restriction 
enzymes. The ligations were transformed into E. coli DH5α competent cells and 
kanamycin resistant colonies were screened by colony PCR using T7 promoter and 
T7 terminator primers. Plasmids were extracted from E. coli and all plasmids were 
then transformed into E. coli overexpression strains (BL21 DE3) to overexpress the 
histidine-tagged proteins. The solubility of each protein was double checked with 
SDS-PAGE. 
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(A)                         (B) 
1   2   3   4   5          1        2 
       
 
Figure 4.9 Analysis of PCR products following amplification of flm locus 
gene fragments using pET-28a-flmA-His, pET-28a-flmB-His, 
pMAL-c5X-flmD, pET-28a-neuB-His and pET-28a-neuA-His as template. 
PCR was carried out using Q5 DNA polymerase and pET-28a-flmA-His, 
pET-28a-flmB-His, pMAL-c5X-flmD, pET-28a-neuB-His and pET-28a-neuA-His. 5 ul 
of the PCR products were observed following electrophoresis in a 1% agarose gel. 
Primers used to amplify these products are T7 forward primer and T7 reverse primer 
and pMAL sequence forward primer and pMAL sequence reverse primer. (A) Lane1, 
2-Log linear DNA ladder; lane 2, flmA gene fragment (1299bp); lane 3, flmB gene 
fragment (1450bp); lane 4, flmD gene fragment (1718bp); lane 5, neuA gene fragment 
(973bp); (B) Lane1, 2-Log linear DNA ladder; lane 2, neuB gene fragment (1345bp). 
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Table 4.2 Plasmids with flm gene insertions applied in this project and 
expected expressed Proteins (Tabei et al. 2009). 
Name of plasmids Protein expressed  Protein size (kDa) 
pBBR1-MCS-neuA-His His-NeuA 27.8 
pET-28-flmA-His His-FlmA 40 
pET-28-flmB-His His-FlmB 45 
pMAL-c5X-flmD MBP-FlmD 98.8 
pET-28-neuB-His His-NeuB 40.6 
pET-28-neuA-His His-NeuA 27.8 
 
Firstly, each plasmid was collected from E. coli DH5α by mini-preparation and 
they were retransformed into E. coli BL21 (DE3). Each strain was grown in LB broth 
with appropriate antibiotics for 2 hours and then the culture was split in two and 1mM 
IPTG was added to one culture (+IPTG) and one culture without IPTG (-IPTG) (figure 
4.10, figure 4.11 and figure 4.12). After that, each strain was grown in LB broth 
following section 2.19 protein overexpression protocol and the supernatant and pellet 
of each protein was checked by SDS-PAGE to make sure that all the proteins were 
soluble (figure 4.10, figure 4.11 and figure 4.12). The overexpressed protein in the 
supernatant and pellet were collected. It has been confirmed that all proteins obtained 
from protein purification were soluble. Based on the results of SDS-PAGE, FlmA, 
FlmB, NeuA and NeuB have been prepared successfully. Each protein was isolated 
and purified by application to a His-trap column to which a gradient of imidazole was 
applied. 
 
 FlmA which is about 40kDa was purified and most of the protein was eluted in 
EB with 150mM of imidazole and 200mM of imidazole (figure 4.13). FlmB which is 
approximately 45kDa was purified and most of the protein was eluted in EB with 
100mM imidazole, 150mM imidazole and 200mM imidazole (figure 4.14). NeuA which 
is about 27.8kDa was purified and most of the protein was eluted in EB with 150mM 
imidazole and 200mM imidazole (figure 4.15). NeuB which is about 40.6kDa was 
purified and most of the protein was eluted in Elution Buffer with 150mM of imidazole 
and 200mM of imidazole (Figure 4.16). The protein overexpression of FlmD was 
carried out by MBP-tag protein purification protocol via 2.22 and purified FlmD was 
eluted into 50mM maltose buffer (Figure 4.17). All 6 enzymes are shown in Figure 
4.18. 
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Figure 4.10 Analysis of protein overexpression and solubility of 
His-tagged FlmA and His-tagged NeuB.  
His-tagged FlmA and NeuB were expressed from pET-28a-flmA-His and 
pET-28a-neuB-His in E. coli strain BL21 (DE3). Cells were grown in LB broth at 37°C 
with or without 1mM IPTG addition for 3 hours. Cells were disrupted by sonication and 
separated into soluble and insoluble fractions (supernatant and pellet) by 
centrifugation.    
 
10 μl of the protein samples were electrophoresed in a 12% SDS polyacrylamide 
gel. Lane 1, Prestained protein ladder (sizes shown in kDa) (Appendix 1); Lane 2, 
total protein from induced cells with pET-28a-flmA-His in supernatant (soluble 
fraction); Lane 3, total protein from induced cells with pET-28a-flmA-His in pellet 
(insoluble fraction); Lane 4, total protein from induced cells with pET-28a-flmA-His; 
Lane 5, total protein from uninduced cells with pET-28a-flmA-His. Lane 6, total protein 
from induced cells with pET-28a-neuB-His in supernatant (soluble fraction); Lane 7, 
total protein from induced cells with pET-28a-neuB-His in pellet (insoluble fraction); 
Lane 8, total protein from induced cells with pET-28a-neuB-His; Lane 9, total protein 
from uninduced cells with pET-28a-neuB-His. The difference between lane 4 and 5 is 
caused by the addition of IPTG. Induced cells expressed more His-tagged FlmA than 
uninduced cells. The difference between lane 8 and 9 is caused by the addition of 
IPTG. Induced cells expressed more His-tagged NeuB than uninduced cells. 
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Figure 4.11 Analysis of protein overexpression and solubility of 
His-tagged FlmB.  
His-tagged FlmB were expressed from pET-28a-flmB-His and in E. coli strain 
BL21 (DE3). Cells were grown in LB broth at 37°C with or without 1mM IPTG addition 
for 3 hours. Cells were disrupted by sonication and separated into soluble and 
insoluble fractions (supernatant and pellet) by centrifugation. 10 μl of the protein 
samples were electrophoresed in a 12% SDS polyacrylamide gel. Lane 1, Prestained 
protein ladder (sizes shown in kDa); Lane 2, total protein from induced cells with 
pET-28a-flmB-His in supernatant (soluble fraction); Lane 3, total protein from induced 
cells with pET-28a-flmB-His in pellet (insoluble fraction); Lane 4, total protein from 
induced cells with pET-28a-flmB-His; Lane 5, total protein from uninduced cells with 
pET-28a-flmB-His. The difference between lane 4 and 5 is caused by the addition of 
IPTG. Induced cells expressed more His-tagged FlmB than uninduced cells. 
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Figure 4.12 Analysis of protein overexpression and solubility of 
His-tagged NeuA and NeuA.  
His-tagged NeuA and NeuA were expressed from pET-28a-neuA-His and 
pBBR1-MCS-neuA-His in E. coli strain BL21 (DE3). Cells were grown in LB broth at 
37°C with or without 1mM IPTG addition for 3 hours. Cells were disrupted by 
sonication and separated into soluble and insoluble fractions (supernatant and pellet) 
by centrifugation. 10 μl of the protein samples were electrophoresed in a 12% SDS 
polyacrylamide gel. Lane 1, Prestained protein ladder (sizes shown in kDa); Lane 2, 
total protein from induced cells with pET-28a-neuA-His in supernatant (soluble 
fraction); Lane 3, total protein from induced cells with pET-28a-neuA-His in pellet 
(insoluble fraction); Lane 4, total protein from induced cells with pET-28a-neuA-His; 
Lane 5, total protein from uninduced cells with pET-28a-neuA-His. Lane 6, total 
protein from induced cells with pBBR1-MCS-neuA-His in supernatant (soluble 
fraction); Lane 7, total protein from induced cells with pBBR1-MCS-neuA-His in pellet 
(insoluble fraction); Lane 8, total protein from induced cells with 
pBBR1-MCS-neuA-His; Lane 9, total protein from uninduced cells with 
pBBR1-MCS-neuA-His. The difference between lane 4 and 5 is caused by the 
addition of IPTG. Induced cells expressed more His-tagged NeuA than uninduced 
cells. The difference between lane 8 and 9 is caused by the addition of IPTG. Induced 
cells expressed more NeuA than uninduced cells. 
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Figure 4.13 Analysis of protein purification of the His6-tagged FlmA. 
12% SDS-PAGE gel showing the purification of His-FlmA protein. His-tagged 
FlmA was expressed from pET-28a-flmA-His in E. coli strain BL21 (DE3). Cells were 
grown in LB broth at 37°C with 1mM IPTG addition for 3 hours. The soluble 
supernatant was applied to a HisTrapTM HP Column. Unbound proteins were washed 
off in elution buffer (flow-though and wash). His-tagged FlmA (40kDa) was eluted in 
increasing concentrations of imidazole (50mM-500mM) elution buffer (EB). 10 μl of 
the protein samples were electrophoresed in a 12% SDS polyacrylamide gel. Lane 1, 
Prestained protein ladder (sizes shown in kDa); Lane 2, total protein from induced 
cells with pET-28a-flmA-His in supernatant (soluble fraction); Lane 3, total protein 
from induced cells with pET-28a-flmA-His in flow-though; Lane 4, total protein from 
induced cells with pET-28a-flmA-His after filtration; Lanes 5-12, protein from induced 
cells containing pET-28a-flmA-His eluted in 50,100, 150, 200, 250, 300, 400 and 500 
mM of imidazole elution buffer, respectively. 
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Figure 4.14 Analysis of protein purification of the His6-tagged FlmB. 
His-tagged FlmB was expressed from pET28a-flmB-His in E. coli strain BL21 
(DE3). Cells were grown in LB broth at 37°C with 1mM IPTG addition for 3 hours. The 
soluble supernatant was applied to a HisTrapTM HP Column. Unbound proteins were 
washed off in elution buffer (flow-though and wash). His-tagged FlmB (45kDa) was 
eluted in increasing concentrations of imidazole (50mM-500mM) elution buffer (EB). 
10 μl of the protein samples were electrophoresed in a 12% SDS polyacrylamide gel. 
Lane 1, Prestained protein ladder (sizes shown in kDa); Lane 2, total protein from 
induced cells with pET28a-flmB-His in supernatant (soluble fraction); Lane 3, total 
protein from induced cells with pET28a-flmB-His in flow-though; Lane 4, total protein 
from induced cells with pET28a-flmB-His after filtration; Lanes 5-12, protein from 
induced cells containing pET-28a-flmB-His eluted in 50,100, 150, 200, 250, 300, 400 
and 500 mM of imidazole elution buffer, respectively. 
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Figure 4.15 Analysis of protein purification of the His6-tagged NeuA. 
His-tagged NeuA was expressed from pET-28a-neuA-His in E. coli strain BL21 
(DE3). Cells were grown in LB broth at 37°C with 1mM IPTG addition for 3 hours. The 
soluble supernatant was applied to a HisTrapTM HP Column. Unbound proteins were 
washed off in elution buffer (flow-though and wash). His-tagged NeuA (27.8kDa) was 
eluted in increasing concentrations of imidazole (50mM-500mM) elution buffer (EB). 
10 μl of the protein samples were electrophoresed in a 12% SDS polyacrylamide gel. 
Lane 1, Prestained protein ladder (sizes shown in kDa); Lane 2, total protein from 
induced cells with pET-28a-neuA-His in supernatant (soluble fraction); Lane 3, total 
protein from induced cells with pET-28a-neuA-His in flow-through; Lane 4, total 
protein from induced cells with pET-28a-neuA-His after filtration; Lanes 5-12, protein 
from induced cells containing pET-28a-neuA-His eluted in 50,100, 150, 200, 250, 300, 
400 and 500 mM of imidazole elution buffer, respectively. 
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Figure 4.16 Analysis of protein purification of the His6-tagged NeuB. 
His-tagged NeuB was expressed from pET-28a-neuB-His in E. coli strain BL21 
(DE3). Cells were grown in LB broth at 37°C with 1mM IPTG addition for 3 hours. The 
soluble supernatant was applied to a HisTrapTM HP Column. Unbound proteins were 
washed off in elution buffer (flow-though and wash). His-tagged NeuB (40.6kDa) was 
eluted in increasing concentrations of imidazole (50mM-500mM) elution buffer (EB). 
10 μl of the protein samples were electrophoresed in a 12% SDS polyacrylamide gel. 
Lane 1, Prestained protein ladder (sizes shown in kDa); Lane 2, total protein from 
induced cells with pET-28a-neuB-His in supernatant (soluble fraction); Lane 3, total 
protein from induced cells with pET-28a-neuB-His in flow-though; Lane 4, total protein 
from induced cells with pET-28a-neuB-His after filtration; Lanes 5-12, protein from 
induced cells containing pET-28a-neuB-His eluted in 50,100, 150, 200, 250, 300, 400 
and 500 mM of imidazole elution buffer, respectively. 
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Figure 4.17 Analysis of protein purification of the MBP-tagged FlmD. 
MBP-tagged FlmD was expressed from pMAL-c5X-flmD in E. coli strain ER2523 
(NEB Express). Cells were grown in LB broth at 37°C with 1mM IPTG addition for 3 
hours. The soluble supernatant was applied to a MBPTrapTM HP Column. Unbound 
proteins were washed off in elution buffer (flow-though and wash). MBP-tagged FlmD 
(100kDa) was eluted in increasing concentrations of maltose (20mM-300mM) column 
buffer (CB). 10 μl of the protein samples were electrophoresed in a 12% SDS 
polyacrylamide gel. Lane 1, Prestained protein ladder (sizes shown in kDa); Lane 2, 
total protein from induced cells with pMAL-c5x-flmD in supernatant (soluble fraction); 
Lane 3, total protein from induced cells with pMAL-c5x-flmD in flow-through; Lane 4, 
total protein from induced cells with pMAL-c5x-flmD after filtration; Lanes 5-12, protein 
from induced cells containing pMAL-c5X-flmD eluted in 20, 50, 100, 150, 200, 250 
and 300 mM of column buffer, respectively. 
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Figure 4.18 Analysis of protein overexpression of purified FlmA, FlmB 
FlmD, NeuB and NeuA. 
The proteins including His-tagged FlmA, His-tagged FlmB, His-tagged NeuB and 
His-tagged NeuA were expressed from pET-28a-flmA-His, pET-28a-flmB-His, 
pET-28a-neuA-His and pET-28a-neuB-His in E. coli strain BL21 (DE3). MBP-tagged 
FlmD was expressed from pMAL-c5X-flmD in E. coli (NEB Express). The proteins 
were then purified either using His-trap or MBP-trap column.  
 
Cells were grown in LB broth at 37°C with or without 1mM IPTG addition for 3 
hours. 10 μl of the protein samples were electrophoresed in a 12% SDS 
polyacrylamide gel. Lane 1, Prestained protein ladder (sizes shown in kDa); Lane 2, 
purified FlmA from induced cells with pET-28a-flmA-His in supernatant (soluble 
fraction); Lane 3, purified FlmB from induced cells with pET-28a-flmB-His in 
supernatant (soluble fraction); Lane 4, purified FlmD protein from induced cells with 
pMAL-c5X-flmD in supernatant (soluble fraction); Lane 5, purified NeuB from induced 
cells with pET-28a-neuB-His in supernatant (soluble fraction). Lane 6, purified NeuA 
from induced cells with pET-28a-neuA-His in supernatant (soluble fraction). 
 
4.6 CMP-Pse5Ac7Ac biosynthetic reactions 
This project aimed to produce CMP-Pse from the starting substrate UDP-GlcNAc. 
Previous workers have reconstituted the CMP-Pse5Ac7Ac biosynthesis pathway from 
H. pylori (Schoenhofen et al. 2006). The starting substrate was shown to be 
UDP-GlcNAc. We wished to do the same for the A. caviae pathway to allow us to 
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access CMP-Pse5Ac7Ac the final product of the pathway. In collaboration with a 
fellow PhD student Joe Ferner the enzymatic activity of FlmA (PseB) was investigated 
by NMR. FlmA is thought to have 
UDP-N-acetylglucosamine 5-inverting 4, 6-dehydratase activity. Previous workers 
have shown the activity of this enzyme can be followed by NMR (McNally et al. 2008). 
 
In this project, one of the aims was to reconstitute the CMP-Pse5Ac7Ac 
biosynthesis pathway and generate CMP-Pse5Ac7Ac from UDP-GlcNAc, L-Glu, 
Acetyl-CoA and PEP via enzymes encoded by flm locus from A. caviae. The reactions 
occurred in NMR tube and whole reaction process is monitored by Nuclear magnetic 
resonance spectroscopy (NMR). 
 
However, the NMR trace for UDP-GlcNAc did not change (Figure 4.19). There is 
no reaction detected after 4 hours, therefore the FlmA enzyme appeared to be 
inactive. The enzyme was soluble when purified, therefore circular dichroism was 
performed to see if it had folded correctly (Figure 4.20). The change in signal between 
200-230nm depicts alpha helix formation, suggesting the protein is folded. 
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Figure 4.19 data of NMR spectrum of UDP-GlcNAc in 10% D2O phosphate 
buffer. 
The figure shows 1H NMR spectrum of UDP-GlcNAc in 10% D2O phosphate 
buffer.  The first enzyme in the biosynthesis pathway is FlmA (PseB). However when 
purified FlmA was incubated with UDP-GlcNAc and the reaction followed for 4 hours 
using 1 ml NMR reaction mix as previously described, there was no change in the 
UDP-GlcNAc spectra (McNally et al. 2008).  
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Figure 4.20 CD spectra of FlmA 
The data of CD spectra of FlmA shows that FlmA has negative peaks at 220nm 
and 210nm and a positive one at 196nm. The characteristicsof these CD signals are 
corresponded to alpha helix which is secondary structure of protein. 
 
Based on the result of NMR reaction of UDP-GlcNAc and FlmA, there is no 
product detected after overnight reaction. This result suggests that the FlmA is 
inactive and further NMR reactions are all held due to the lack of 
UDP-2-acetamido-2,6-dideoxy-b-L-arabinohexos-4-ulose.  
 
Emily Flack (University of York) and her co-worker were investigating a similar 
CMP-Pse5Ac7Ac biosynthetic pathway in Helicobacter pylori (Table 4.3). The 
pseudaminic acid can be generated from UDP-GlcNAc via purified PseB, PseC, PseH, 
PseG and PseI of H. pylori. PseB from H. pylori is homologue of FlmA from A. caviae 
and UDP-2-acetamido-2,6-dideoxy-b-L-arabinohexos-4-ulose has been proved to be 
generated from UDP-GlcNAc via PseB (Schoenhofen et al. 2006). All 5 enzymes 
were taken to York University for further testing. The activity of each enzyme has been 
tested via a series of reactions and followed by LC-MS. The reactions involved in the 
CMP-Pse5Ac7Ac biosynthetic pathway are shown in Figure 4.21. FlmA (PseB) which 
is a dehydratase initiates the biosynthesis of pseudaminic acid via catalyzing the 
conversion of UDP-N-acetylglucosamine (UDP-GlcNAc) (607.35 g/mol) to 
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UDP-2-acetamido-2,6-dideoxy-b-L-arabino-hexos-4-ulose (589.34 g/mol). FlmB 
(PseC) which is aminotransferase catalyzes 
UDP-2-acetamido-2,6-dideoxy-b-L-arabino-hexos-4-ulose and L-glutamine and result 
in UDP-4-amino-4,6-dideoxy-b-L-AltNAc (590.372 g/mol) and a-ketoglutarate. After 
processing by FlmD (PseH/PseG) which is acetyltransferase and nucleotidase, the 
UDP-4-amino-4,6-dideoxy-b-L-AltNAc was catalyzed to 
2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose (246.26 g/mol). The acetyl group 
was induced and UDP group was removed in this process. NeuB (PseI) which is 
pseudaminic acid synthetase catalyzes PEP and 
2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose and result in pseudaminic acid 
(334.32g/mol)and phosphate  (Schoenhofen et al. 2006; Schirm et al. 2003). NeuA 
(PseF) is acts as CMP-sugar synthetase and catalyzes pseudaminic acid and CTP 
and result in CMP-Pse5Ac7Ac (639.50 g/mol) and pyrophosphate(Schirm et al. 2003). 
 
Table 4.3 Enzymes from A. caviae and corresponding homologues from H. 
pylori. 
Enzyme in A. caviae  Homologues in H. pylori  
FlmA PseB 
FlmB PseC 
FlmD PseH/PseG 
NeuB PseI 
NeuA PseF 
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Figure 4.21 The proposed CMP-Pse5Ac7Ac biosynthetic pathway in A. 
caviae. 
This diagram shows CMP-Pse5Ac7Ac is synthesized from 
UDP-N-acetylglucosamine via FlmA, FlmB, FlmD, NeuB and NeuA (Schoenhofen et 
al. 2006). FlmA (PseB) initiates the biosynthesis of pseudaminic acid via catalyzes 
UDP-N-acetylglucosamine (UDP-GlcNAc) to 
UDP-2-acetamido-2,6-dideoxy-b-L-arabino-hexos-4-ulose. Subsequently, the product 
modified by FlmB (PseC) and UDP-4-amino-4,6-dideoxy-b-L-AltNAc is generated. 
After processed by FlmD (PseH/PseG), 
2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose is generated. Eventually, 
2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose is catalyzed by NeuB (PseI) and 
results in pseudaminic acid (Schoenhofen et al. 2006; Schirm et al. 2003). The 
pseudaminic acid is activated by NeuA (PseF) and results in CMP-Pse5Ac7Ac 
(Schirm et al. 2003) 
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(B) 
 
(C)                                                  
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(D) 
 
                     
Figure 4.22 LCMS data of reactions of PseB and PseC from H. pylori and 
FlmA and FlmB from A. caviae. 
Peak 606 m/z indicates UDP-GlcNAc and peak 589 m/z indicates 
UDP-4-amino-4,6-dideoxy-b-L-AltNAc. All data was collected after 4 hours of 
reaction. 
 
(A) The reaction mixture with PseC from H. pylori, showing no conversion to product. 
  
(B) The reaction mixture with FlmA from A. caviae and PseC from H. pylori after 4 
hours reacting, showing no conversion to product. 
 
(C) The reaction mixture with FlmA from A. caviae and PseC from H. pylori after 
leaving overnight (more FlmA from A. caviae had been added after 6 hours), showing 
no conversion to product.  
 
(D) The reaction mixture with PseB from H. pylori and FlmB from A. caviae after 
leaving overnight, showing some conversion to 
product (UDP-4-amino-4,6-dideoxy-b-L-AltNAc). 
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Figure 4.23 LC-MS data of reactions of PseB, FlmB, FlmD and NeuB 
Peak 244 m/z indicates 2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose; peak 
333 m/z indicates pseudaminic acid; peak 606 m/z indicates UDP-GlcNAc and peak 
589 m/z indicates UDP-4-amino-4,6-dideoxy-b-L-AltNAc. All data was collected after 
4 hours of reaction. 
 
(A) The reaction mixture with PseB from H. pylori and FlmB from A. caviae after 
leaving overnight. There is no loss of the FlmB product 
(UDP-4-amino-4,6-dideoxy-b-L-AltNAc) without FlmD. 
 
(B) The reaction mixture with PseB from H. pylori and FlmB and FlmD from A. caviae 
after leaving overnight showing complete loss of the FlmB product and some residual 
UDP-GlcNAc. 
 
(C) The reaction mixture with PseB from H. pylori and FlmB, FlmD and NeuB from A. 
caviae, showing formation of pseudaminic acid. 
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Figure 4.24 LC-MS data of reaction of NeuA from A. caviae 
Peak 333 m/z indicates pseudaminic acid, peak 638 m/z indicates 
CMP-pseudaminic acid and peak 481 m/z indicates CTP. Reaction conditions: 5 mM 
Pse5Ac7Ac, 1.5 mM CTP, 10 mM MgCl2, 50 mM NaCl, 25 mM sodium phosphate, pH 
7.4, 360 µgmL-1 NeuA.The enzyme control was not included. 
(A) Initially reactions were performed at 5 mM Pse5Ac7Ac (4 hours), showing 
formation of CMP-pseudaminic acid. 
 
(B) Initially reactions were performed at 5 mM Pse5Ac7Ac (4+6.5 hours, at 25 °C), 
showing formation of CMP-pseudaminic acid. 
 
(C) Reaction mix without Pse5Ac7Ac (control group), showing no formation of 
CMP-pseudaminic acid. 
 
(D) Initially reactions were performed at 0.5 mM Pse5Ac7Ac (4+2.5 hours, at 25 °C), 
showing no formation of CMP-pseudaminic acid. 
4.7 Discussion 
NeuA which is encoded by the neuA gene is the CMP-sugar synthetase in A. 
caviae Sch3N. The function of neuA was to be investigated in this project. Firstly, a 
mutant strain A. caviae Sch3N neuA::Km was constructed via PCR, ISA, conjugation 
and allelic exchange. This strain is a neuA insertional knockout and is kanamycin 
resistant. Swimming ability of this strain has been confirmed to be abolished which 
means neuA is essential for the biosynthesis of the functional polar flagella (Figure 
4.5A). Then, two complementing strains which are A. caviae neuA mutant 
(pBBR1-MCS-neuA) and A. caviae neuA mutant (pBBR1-MCS-neuA-His) were 
constructed via conjugation of these plasmids into the mutant strain. The strain A. 
caviae neuA mutant (pBBR1-MCS-neuA) contains pBBR1-MCS-neuA which was able 
to compensate the swimming ability of A. caviae neuA mutant (Figure 4.5B). The 
strain A. caviae neuA mutant (pBBR1-MCS-neuA-His) contains 
pBBR1-MCS-neuA-His which was able to complement the swimming ability of A. 
caviae neuA mutant (Figure 4.5C). This finding indicates that His-NeuA which is 
encoded by pBBR1-MCS-neuA-His has the same ability of NeuA and that the addition 
of an N-terminal His-tag to this protein does not affect its activity. The previous 
reported neuA mutant had a polar effect on downstream genes including flmD and 
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neuB, as the introduction of pBBR1-MCS-neuA or pBBR1-MCS-neuA-His into this 
strain did not rescue the phenotype of the mutant (Tabei et al. 2009). These results 
suggest we would be able to purify an active His-tagged NeuA enzyme from A. caviae 
if the pET-28a-neuA-His overexpression did not work and resulted in soluble protein. 
However, we are able to recover soluble His-tag NeuA from E. coli, this enzyme was 
subsequently shown to be active (Figure 4.18). 
 
Secondly, the LPS of A. caviae neuA mutant was analyzed. The result from LPS 
extraction confirmed that the LPS from this mutant lacked O-specific polysaccharides 
which contains pseudaminic acid (Tabei et al. 2009) (Figure 4.7). According to Figure 
4.7, only the core oligosaccharide (OS) was detected and O-specific polysaccharides 
were absent in A. caviae neuA mutant. The LPS of A. caviae neuA mutant 
(pBBR1-MCS-neuA) and A. caviae neuA mutant (pBBR1-MCS-neuA-His) were as 
same as the LPS of A. caviae Sch3N wild type which means the LPS biosynthesis in 
these stains were restored. This finding indicates that neuA is essential for the 
biosynthesis of functional LPS and it is related to O-specific polysaccharide as 
previously Tabei et al 2009 showed Pse5Ac7Aac to be present in the LPS of the 
strain. Based on the result of western blot of polar flagellin of these strains, the 
biosynthesis of functional flagellin was abolished in A. caviae neuA mutant (Figure 
4.8). This finding is match to the result of swimming ability assay and the previously 
reported findings of Tabei et al (2009). 
 
Based on the information above, the results of swimming ability assay, western 
blot and LPS extraction are all in accordance with the hypothesis. The NeuA-His has 
been expressed in A. caviae and produces an active enzyme. Which make it is 
possible to generate CMP-Pse5Ac7Ac via NeuA-His and Pse5Ac7Ac. 
 
The A. caviae flmA mutant strain was found to be non-motile compared to 
wild-type (WT) (figure 4.5E). Swimming ability of this strain has been confirmed to be 
abolished which means flmA is essential for the biosynthesis of the functional polar 
flagella (Figure 4.5E). 
 
The flm locus which is involved in pseudaminic acid biosynthesis is an important 
target of this study. With the help of the proteins encoded by the flm genes, it is 
possible to reconstruct the pseudaminic acid biosynthetic pathway and generate 
Pse5Ac7Ac and CMP-Pse5Ac7Ac. The plasmids which contain the flm genes some 
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of which have been constructed by former researchers, but whether the proteins 
encoded by these plasmids are soluble were still needed to be confirmed. Based on 
the progress of experiment, all of the plasmids with flm gene insertion were extracted 
via mini-preparation successfully. The overexpression and purification of each protein 
have been has been shown. Based on the figure 4.13, figure 4.14, figure 4.15, figure 
4.16 and figure 4.17, it is obvious that the bands of FlmA, FlmB, FlmD, NeuA and 
NeuB were thick and high amount of nearly pure protein is visible on SDS-PAGE gels. 
Based on the results of protein purification, a protein of about 40kDa was purified 
according to Figure 4.13 and the presumed protein is FlmA. A protein which is about 
45kDa was purified according to Figure 4.14 and the presumed protein is FlmB. A 
protein of about 100kDa was purified according to Figure 4.17 and the presumed 
protein is FlmD. A protein of about 28kDa was purified according to Figure 4.15 and 
the presumed protein is NeuA. A protein of about 41kDa was purified according to 
Figure 4.16 and the presumed protein is NeuB.  
 
With the help of these 5 enzymes, generation of CMP- Pse5Ac7Ac was 
attempted. His-FlmA did not catalyzed UDP-GlcNAc to 
UDP-2-acetamido-2,6-dideoxy-b-L-arabinohexos-4-ulose. The purified FlmA was 
confirmed to be soluble and well folded. The reason why it is inactivated could be the 
His-tag affected the function of FlmA. Previous research has been proved that FlaA1 
from H. pylori can complement A. caviae flmA mutant(Tabei et al. 2009). 
 
It has been revealed that FlaA1 oligomers that are consistent with the hexameric 
structure derived from crystallographic analysis, this finding suggests that the FlaA1 
enzyme exists as a hexamer in solution(Noboru Ishiyama et al. 2006). Based on that 
result, the reason why FlmA is inactivated could also be the FlmA protomers did not 
combined properly to form a hexamer. The A. caviae flmA mutant strain is suitable for 
conjugation with plasmid expressing FlmA protein. The pBBR1-MCS-flmA will be 
constructed in the further experiment to investigate the function of flmA gene. 
 
His-FlmB, His-FlmD His-NeuA, and His-NeuB were all tested to be soluble. 
Based on the results of enzymatic reactions of His-FlmB, MBP-FlmD His-NeuA, and 
His-NeuB, all of these enzymes are functional and CMP-Pse5Ac7Ac has been 
successfully generated from 
UDP-2-acetamido-2,6-dideoxy-b-L-arabinohexos-4-ulose via these enzymes.  
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FlmB (PseC) which is aminotransferase catalyzes 
UDP-2-acetamido-2,6-dideoxy-b-L-arabino-hexos-4-ulose and L-glutamine and result 
in UDP-4-amino-4,6-dideoxy-b-L-AltNAc (590.372 g/mol) and a-ketoglutarate. 
His-FlmB has been proved to be functional and this finding indicates that His-tag did 
not affect the function of FlmB. After processed by FlmD (PseH/PseG) which is 
acetyltransferase and nucleotidase, the UDP-4-amino-4,6-dideoxy-b-L-AltNAc was 
catalyzed to 2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose (246.26 g/mol). The 
acetyl group was induced and UDP group was removed in this process. MBP-FlmD 
has been proved to be functional and this finding indicates that MBP-tag did not affect 
the function of FlmD. Besides, FlmD has the same ability of PseH and PseG from H. 
pylori or Cj1312 and Cj1313 from C. jejuni (Liu and Tanner 2006; McNally et al. 2006). 
NeuB (PseI) which is pseudaminic acid synthetase catalyzes PEP and 
2,4-diacetamido-2,4,6-trideoxy-b-L-altropyranose and result in pseudaminic 
acid(334.32g/mol) and phosphate  (Schoenhofen et al. 2006; Schirm et al. 2003). 
His-NeuB has been proved to be functional and this finding indicates that His-tag did 
not affect the function of NeuB. NeuA (PseF) is acts as CMP-sugar synthetase and 
catalyzes pseudaminic acid and CTP and result in CMP-Pse5Ac7Ac and 
pyrophosphate(Schirm et al. 2003). His-NeuA has been proved to be functional which 
is capable to produce CMP-Pse5Ac7Ac from Pse5Ac7Ac. This finding indicates that 
His-NeuA has the same function as NeuA and His-tag did not affect the function of 
NeuA. Furthermore, CMP- Pse5Ac7Ac has been generated successfully and it can be 
applied to glycosylate FlaA with the help of Maf1.  
 
4.8 Conclusion 
FlmA, FlmB, FlmD, NeuA and NeuB were all successfully expressed from 
plasmids. Based on the result of SDS-PAGE, 5 proteins were all purified and proved 
to be soluble, but His-FlmA proved to be well folded but inactivated (Figure 4.18 and 
Figure 4.19). 
 
It has been confirmed that pseudaminic acid can be generated from UDP-GlcNAc 
via PseB from H. pylori, FlmB, FlmD and NeuB from A. caviae. His-FlmB has been 
proved to be functional and this finding indicates that His-tag did not affect the 
function of FlmB. MBP-FlmD has been proved to be functional and this finding 
indicates that MBP-tag did not affect the function of FlmD. Besides, FlmD has the 
same ability of PseH and PseG from H. pylori or Cj1312 and Cj1313 from C. jejuni. 
His-NeuB has been proved to be functional and this finding indicates that His-tag did 
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not affect the function of NeuB. CMP-Pse5Ac7Ac has been successfully generated 
from Pse5Ac7Ac which was catalyzed by His-NeuA. His-NeuA has the same function 
as NeuA and His-tag did not affect the function of NeuA (Figure 4.22, Figure 4.23 and 
Figure 4.24). 
 
The biosynthesis of functional flagellin was abolished in A. caviae neuA mutant 
and this strain did not have polar effect. The palsmids including 
pBBR1-MCS-neuA-His and pBBR1-MCS-neuA can both complement A. caviae neuA 
mutant. His-NeuA which is encoded by pBBR1-MCS-neuA-His has the same ability of 
NeuA and that the addition of an N-terminal His-tag to this protein does not affect its 
activity (Figure4.5 and Figure 4.6). 
 
The A. caviae flmA mutant strain was found to be non-motile compared to 
wild-type (WT) (Figure 4.5E). Swimming ability of this strain has been confirmed to be 
abolished which means flmA is essential for the biosynthesis of the functional polar 
flagella (Figure 4.5E). 
 
LPS from A. caviae neuA mutant lacked O-specific polysaccharides which 
contain pseudaminic acid and the plasmids including pBBR1-MCS-neuA-His and 
pBBR1-MCS-neuA can restore this defect in A. caviae neuA mutant (Figure 4.7). This 
finding suggests that neuA is essential for the biosynthesis of functional LPS and it is 
related to O-specific polysaccharide. This result is corresponding to the result that 
his-NeuA encoded by pBBR1-MCS-neuA-His has the same ability as NeuA encoded 
by pBBR1-MCS-neuA. Based on the result of western blot of polar flagellin of these 
strains, the biosynthesis of functional flagellin was abolished in A. caviae neuA mutant 
(Figure 4.8). This finding is match to the result of swimming ability assay and the 
previously reported findings of Tabei et al (2009). 
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Chapter 5 Conclusions 
 
The aim of this project was to investigate proteins associated with flagellar 
glycosylation in Aeromonas caviae. 
 
Maf1 the motility-associated factor is involved in polar flagellar biosynthesis and it 
is thought to be the glycosyl-transferase that directly transfer of pseudaminic acid onto 
the polar flagellin proteins in A. caviae Sch3N (Tabei et al. 2009; Parker et al. 2012). 
The Maf1 protein is deemed as a putative flagellin pseudaminyl-transferase (Parker et 
al. 2012). Theoretically, Maf1 of A. caviae Sch3N has the ability to transfer activated 
pseudaminic acid (CMP-Pse5Ac7Ac) to the hydroxyl group of serine and threonine 
residues in the central immunogenic D2/D3 domain of flagellin of A. caviae Sch3N 
(Parker et al. 2012; Tabei et al. 2009). Flagellin proteins, are usually insoluble, 
previous work has shown that the C-terminal chaperone binding domain of the A. 
caviae flagellin FlaA is not involved in the glycosylation process (Parker et al. 
2014)(Parker et al 2014). Identification of the site where Maf1 binds is crucial for the 
investigation of glycosylation of flagellin. Attempts have been made to create deletion 
derivatives of flagellin that are still glycosylated and are more soluble to provide more 
suitable substrate for future glycosylation assays. 
 
The plasmids including pBBR1-MCS-flaA0+~pBBR1-MCS-flaA15+ and 
pBBR1-MCS-flaA0-~pBBR1-MCS-flaA15- are all functional and producing FlaA or 
FlaA deletion derivatives in the conjugated strains. pBBR1-MCS-flaA0- can produce 
fully functional FlaA and partially restore the swimming ability of A. caviae flaA-flaB 
mutant. The pBBR1-MCS-flaA0+ can not restore the swimming ability of A. caviae 
flaA-flaB mutant. The rest of all plasmids with flaA gene deletion can not restore the 
swimming ability of A. caviae flaA-flaB mutant. This result indicates that complete 
FlaA encoded by pBBR1-MCS-flaA0- is essential for the flagella assembly and 
deletion in flaA gene will result in absence of functional flagella. Expression of the 
complete flaA gene (flaA0-) in the minus orientation with the lacZ promoter resulted in 
complementation, whereas in the plus orientation it did not, this suggests expression 
of the flagellin is better or greater in the minus orientation. The possible reason for this 
result is better expression from the lac promoter. 
 
However, expression of FlaA0- only resulted in partial (50%) recovery of motility 
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in the mutant strain, this is in agreement with the result from Rabaan et al (2001). This 
suggests that both flagellins are required for optimal flagella filament function, even 
though both flaA and flaB are almost identical to each other (Rabaan et al. 2001). Or 
that the expression leads of the flagellins are not optimal. However, on comparation 
with the normal western blot the flagellin levels of the flaA0- expressing strain do not 
look to be expressed to the high levels when compared to the wild type (Figure 3.8B). 
 
Deletion strains including A. caviae flaA-flaB mutant (pBBR1-MCS-flaA1-) to A. 
caviae flaA-flaB mutant (pBBR1-MCS-flaA15-) are non-motile. This result is probably 
caused by not being bound correctly by FlaJ (CBD removed) (Parker et al. 2012). 
 
Western Blotting of these FlaA deletion derivatives shows that FlaA0- to FlaA9- 
were all glycosylated and FlaA10- to FlaA15- were all unglycosylated. This result 
suggested that the site of Maf1 bind is required is around amino acids 256-250. The 
flagellins after deletion of CBD amino acids 220-250 were still expressed but 
unglycosylated and FlaA10- to FlaA15 did not decompose. However, the abilities of 
binding anti-FlaA antibody of FlaA deletion derivatives are reducing. The explanation 
for this result may be the loss of C-terminal amino acids. Further experiment will be 
applied to determine if Maf1 can bind these FlaA deletion derivatives. Whether the 
FlaA deletion derivatives which lack the CBD amino acids 256-306 can bind the Maf1 
will be investigated in the future. 
 
In order to reconstruct the glycosylation of FlaA in vitro, a source of soluble FlaA 
deletion derivative which still can be glycosylated is required. Based on the results, 
the FlaA8- expressed by pBBR1-MCS-flaA8- and FlaA9- expressed by 
pBBR1-MCS-flaA9- have been tested and the result indicates that the FlaA8- and 
FlaA9- were both detected in the soluble fractions (Figure 3.12). This finding suggests 
that FlaA8- and FlaA9- are soluble and glycosylated which are suitable for the further 
experiments. 
 
Furthermore, to prove that Maf-1 is indeed the glycosyl-transferase the substrate 
for the reaction need to be isolated or created, namely CMP-Pse5Ac7Ac which is the 
activated form of pseudaminic acid. Therefore, in order to create CMP-Pse5Ac7Ac, 
the Flm proteins from the pseudaminic biosynthesis pathway have been 
overexpressed and purified. Hence the biosynthesis of Pse5Ac7Ac and CMP- 
Pse5Ac7Ac can be looked into via these reactions. According to the results of 
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SDS-PAGE of Flm proteins, FlmA, FlmB, FlmD, NeuA and NeuB were all successfully 
expressed from plasmids and all of the proteins were purified and proved to be 
soluble. Unfortunately, initially reaction was performed with UDP-GlcNAc and FlmA 
which turned out to be inactivated. The CD spectra was applied to examine the 
structure of FlmA and the result indicates that FlmA is well folded. In the meanwhile, 
swimming ability assay of A. caviae flmA::Km suggests that the swimming ability of 
this strain has been confirmed to be abolished which means flmA is essential for the 
biosynthesis of the functional polar flagella (Figure 4.5E). 
 
Based on the data of LC-MS, it has been confirmed that FlmB, FlmD, NeuB and 
NeuA are all activated and CMP-Pse5Ac7Ac has been successfully generated from 
UDP-2-acetamido-2,6-dideoxy-b-L-arabinohexos-4-ulose. His-FlmB has been proved 
to be functional and this finding indicates that His-tag did not affect the function of 
FlmB. MBP-FlmD has been proved to be functional and this finding indicates that 
MBP-tag did not affect the function of FlmD. Besides, FlmD has the same ability of 
PseH and PseG from H. pylori or Cj1312 and Cj1313 from C. jejuni. His-NeuB has 
been proved to be functional and this finding indicates that His-tag did not affect the 
function of NeuB. CMP-Pse5Ac7Ac has been successfully generated from 
Pse5Ac7Ac which was catalyzed by His-NeuA. His-NeuA has the same function as 
NeuA and His-tag did not affect the function of NeuA. 
 
It has been proved to be feasible to prepare CMP-Pse5Ac7Ac via Flm protein and 
substrates including UDP-GlcNAc. The unglycosylated FlaA deletion can be produced 
from pBBR1-MCS containing flaA gene deletion (pBBR1-MCS-flaA9-). Maf1 has been 
investigated and prepared by former researchers. With the help of above substrates 
and enzyme, it is possible to reconstruct the FlaA glycosylation in vitro via Maf1, 
CMP-Pse5Ac7Ac and unglycosylated FlaA deletion.  
 
The connections between glycosylation in flagellin biosynthesis and LPS 
O-antigen biosynthesis were summarized. The biosynthesis of functional flagellin was 
abolished in A. caviae neuA mutant and this strain did not have polar effect. The 
palsmids including pBBR1-MCS-neuA-His and pBBR1-MCS-neuA can both 
complement A. caviae neuA mutant. His-NeuA which is encoded by 
pBBR1-MCS-neuA-His has the same ability of NeuA and that the addition of an 
N-terminal His-tag to this protein does not affect its activity. LPS from A. caviae neuA 
mutant lacked O-specific polysaccharides which contain pseudaminic acid and the 
plasmids including pBBR1-MCS-neuA-His and pBBR1-MCS-neuA can restore this 
128 
 
defect in A. caviae neuA mutant. This finding suggests that neuA is essential for the 
biosynthesis of functional LPS and it is related to O-specific polysaccharide. This 
result is corresponding to the result that His-NeuA encoded by pBBR1-MCS-neuA-His 
has the same ability as NeuA encoded by pBBR1-MCS-neuA. 
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Appendix 1  
2-Log linear DNA ladder: 
 
Supercoiled ladder: 
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Prestained protein ladder: 
 
Primers used in the project 
 
flmA-forward: GCGCATATGCTGAATAATAAAACAGTATTAATCAC 
flmA-reverse: GCGGGATCCTCACACTTCAAAGTTGGCAT 
 
flmD-forward: GCGCATATGAAGTTTTTTATTCGCACC 
flmD-reverse: GCGAGGCTTTTATTTTGTCCATAATGG 
 
flaA-forward: GCGCAAGCTTGTTAAATTTTAATAGCTTAGGAGAAAAATCAT 
flaA0-reverse: GCGAAGCTTGAACCTTAGTTCTGCAGCAG 
flaA1-reverse: GCGAAGCTTCAGCAGGGACTACGCAGACTG 
flaA2-reverse: GCGAAGCTTCTGCGGACGCTAATTGGCCTG 
flaA3-reverse: GCGAAGCTTCTGGGCCAGTCAGCTGGAAGC 
flaA4-reverse: GCGAAGCTTAGCGGCCTGTTACAGGATATT  
flaA5-reverse: GCGAAGCTTATTCTGCTTTCACATATTGGC 
flaA6-reverse: GCGAAGCTTGGCGGTCTCTCATGCAAAATC 
flaA7-reverse: GCGAAGCTTATCTGCATCTTAGATACGAGA 
136 
 
flaA8-reverse: GCGAAGCTTAGAACGGGCTTAGCTTACGTT 
flaA9-reverse: GCGAAGCTTGTTTTCCGATTAATTGGCCTG  
flaA10-reverse: GCGAAGCTTCTGGTTGCGTTAGGTGGAATC 
flaA11-reverse: CGCAAGCTTATCCAGACGTTACTGCACCGC 
flaA12-reverse: CGCAAGCTTCGCACCCAGTTATGCTCGCTT 
flaA13-reverse: CGCAAGCTTCTTGCTATCTTAGACTTCCAA 
flaA14-reverse: CGCAAGCTTCAACATAGCTTAAGCAGCAGC 
flaA15-reverse: GCGAAGCTTAAGGCCCAATTAGTTTTGGCT 
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Appendix 2 
Sequence of flm genes and flaA gene 
flmA: 
TCACACTTCAAAGTTGGCATCTACATGAGTTTTTATCAATTCCCGCAGAGACTCCA
CGGTCTCCCACTCAGTGTTAGTACCTGAGTTATATTTGAAACCAAACGGTACTTTT
ACGGCACTATGATGCTTAATATAGTCTTCTTCTGTATGATTGAATGACACAGAAGG
TAAAATTGCGTAATAGCGGCCCAAATCAATTGTGTTCAATGAATCGGTATCTGTAA
TCATCTCTTCATGCAGCTTTTCTCCTGGACGAATACCAACTACCTTCGTCTTGCAT
TCAGGAGATATTGCTGTTGCTATATCTAAAATACGATATGATGGGATTTTTGGCACA
AAAATCTCACCACCGAGATGATGCTCCAGAGCATACATCACCATATTAACACCATC
CTGCAGTGAAATATTAAAACGTGTCATTTCTTCATGGGTGATCGGCAACACACCC
TCAGCACGTTTTTTCAAGAAAAATGGTATTACAGAACCCCGAGACCCCATTACATT
TCCATAGCGAACTACACTGAATCTTATATTTCGCGAACCTTTGATATTATTTGCTGC
TGTAAACAACTTGTCAGAGGTCAGCTTTGTCGCTCCATAAAGATTGATCGGCGCA
CAAGCTTTATCTGTTGACAACGCTACAACTTCTTTTACTCCACACTGCAAAGCAG
CGTGGATAACATTTTCAGCACCATCGACGTTAGTGCGAATGCACTCTGTCGGATT
ATACTCGGCTGTATCTACTTGTTTAATAGCAGCAGCATGAATAATGACATCGATTCC
TTCGCACGCTTGAACCATTCGATTACGATCACGTACATCACCAATGAAAAAGCGC
AGTTGTGGATAATCTTTTTGCGGATAATTTAAACGTAATTCAGATTGCTTTAGTTCA
TCTCGAGAAAAAATGACAATGCGCTTAACTTGGGGGTAGCGCTCAAGGATAGTTT
TTATAAATTGTTTACCAAATGATCCCGTACCACCTGTGATTAATACTGTTTTATTATT
CAGCAT 
 
flmB: 
TTATTTCCCTTCCAATATCTCAGACAATACGCATACTACTTTATCTTGCTGCTCTTC
TGTCATGCCGTGGAACATCGGCAAAGAAATAGCTTCACGATAATATTGCTCTGCC
TCAGGAAAATCACCAGATTTGAATCCCATATCTTCGTAATAAGGCTGTGTATGTAC
AGGTATGTAATGAACATTCACCCCGATACCATTTTCACGTAACGCTTCAAAAACCT
CTCGGTGCGTTAATGAAATATTATTAAGCTGAAGTCGTATAACGTAAAGATGCAAT
CCGGAATGGGTATTTTCTAACTGGAATGGTAAGACTATCGGTAACCGCTTCAAAA
GTCTGTTATAACGGTCAGCCAAGCGATGACGAGCAGCGATAAATTCATCAAGGC
GTTGTATTTGGGTGATCCCTAATGCAGCTTGTAACTCGGTCATTCGGTAGTTAAAG
CCCAAGTCAATCTGTTGATAATACCAACCACCATGACTTTCGCCTTTCATCTGCTC
GATATCACGGGTGATACCATGGCTACGTAACAAGGCCATTTTATCAGCTAAATCTT
TTTGGTTAGTTACCACTGCGCCACCTTCAGCAGTAGTGATAATTTTAACCGGATG
GAAACTAAATACCGTAATGTCGCTGTATCGACAATTGCCAATGGGTTCGTTTAAAT
138 
 
AACTACCGCCGATAGCATGTGATGCATCCTCGATAACTTTAAAGCCATATTCAGTT
GCCAGACGGGAAATCGCTTCCATGTCACAAGGTTGGCCACATAAATGAACAGGA
ACGACTATCTTGGGTAAGGTACCGTTGGCATTAGCTGCAATTAGCTTTTTCTCCAA
TTGCTTCGGACACAGATTATATGTATCTGGATCTATATGTACAAAATCGACTTTGGC
GCCACAATACAAACCGCAATTTGCTGATGCAACAAAAGTAACTGGGCTTGTCCAT
AAAAAATCGCCAGGACCAAGACCCAAAGCCAAACAGGCAATGTGTAGTGCCGAA
GTAGCACTATTTACAGCCAACGCATACGCTGCGCCAGTATGGGTTGTTAAATATTT
TTCAAATTCAGGGACTTTTGGTCCCTGAGTTAGAAAATCAGATTGTAACACCGCA
ACCACGCCATCAATATCTTGCTGGGTGATCTCTTGTTTACCGTATGGAATCAC 
 
flmD: 
TTATTTTGTCCATAATGGTTCTCTTATAAATTTATCTGGCGCTACCTGCTGGTAGCC
AGCGTTAGAAAAAAGGCGCTGCGATGCTATATTTTCGGTCAGTACTGTGGCATGA
ATCCTGATTTTTGGTAGGCATCTATCAAGTAATTTCAAACCTGTTAATCCAATACCC
TGACCATGCTTATTAGGAGCAACAAAAATTGAGATAAGGTAATTGTCAGTACCTAG
TTCATCTAGTCTAACTGCACCACAGGGTTCGCTACTTTCAGCATTAATTATCAAAA
AGAAATAATCTTGCTGGCACTGTATTTTTTTTTCCATCCAGCTTTTGTGCTCTACC
CAACTAGGGGGATTGGGATTAAGCGCATAACGTCTGGTTATTGGATCAGATTGCC
ACTGATAAATCAGTAGAGTATCATCGATTGATACCGGCCTTAGCCTAAATCCTGATA
TTTCTGTATTAGCCATAATAGTATTAATGACTCGTTGCACCCCCTTGCCATCACACA
ACTCGAGATTATTATCTACGTATTCTTTATAATTATTCAACAAGTCATGCAGTGCAG
GGATTAATCTACTTTCAATATCAGACTGTTGTACTAATAAAGCAGCTTGATGTGCCA
ACAATGCTTGGCAAATGGCCTGTTGGTTTTCTGCTATCGGAATTACTATATTTGGT
AATCCCAGACAGGCTCGCTCCCAAGTGGTTGTCCCTGGAGCACCGATGGCCAG
ATCGTGCTCGCTCATCAAGGTTGCCATATCTTGTATAAAATCATGATGAACAACATT
AACACGATCATCACACCACGTTTTCACTGCTTGATAGTGTGGTGCTCGAGGGCTT
AACAGCACGGTAAATACAGCATTAAACTCACTTAACGCCTTAAGTACTCTTAGCGT
CACATTTGGCTCATCAATACCACCAAAGGAGAGTAAAATCCTAGGCTGACGACTG
GCAGGGGCTCGTAGTATCCCCTGATTTCTTATTTTTCCAAATTGTGAAGACAGCA
AGGCGTATGCAACTCCACTTAATACTACAGGCTGCTTGTCTGATATATTAAAACAC
TCAAAATAGGCCTCCGGAGTGCGGTCAAGCGTTTGATCCAGAATCAAATCAGCAT
CATGGGGGCGCACCAGATCATCGATAGACAAAACTTTACAATTTAACGACAGCCT
TATTTCCCGTTCCCACTGAGCATTAATTCCATAATGATCAACTATCAGCCAGTCAG
CGTATACCACACTTTCTAAAACATCTGCAGCGTCTTGTTGCCATGGCACTTGCAA
CCAAGAAGAATAATCAGCCCCATGCTCAGGTCTGATAACAGTTGTCAGAGATGGC
AAGGCAAGCAGATTATGGTTACGCGCAGCAATCAAATCGAGCAAATCACCATCTT
GCGGTCTACAAATAAATGTTACCTGATGACCTGCCGATTTTAAGCCATCGGCTAG
CATTAGGCAGCGCATTACATGGCCGGAACCTATCCAACGTGATGCATCGGTGCG
AATAAAAAACTTCAT 
139 
 
 
neuB: 
TTAAATAAATTCAAATGATAACGGAGTTCCGCGTTTAATATCAACTATAGCCGTTTT
GCCAAGGACTTGCTCTAAATACTTCGGAGCCAAACCAAATCCGGGCCTAATGCTA
CGCACATTATCATTACTTAATACATCCCCAGCTTTAATGTCTCGTATCACATATAGA
GAACGCCGAAATTTGACATTTCCTTTTTCGGCTTCAGTACGCGTATAATTTACGCT
GCCTAATGCTGACCAAGCAGTTTTAGCATCTTTACATAACGCAGCAAGCTCATGA
GGTTCGAGCGAGAAGCTATCATCAGCGCCCCCGCCATTTCTATCCATGGTGACAT
GCTTTTCGATTAAACAAGCCCCCAAGGCTACCGCGGCCACAGCGGTGGCATTAT
CGATAGTGTGATCAGACAAGCCAGATAGCACACCAAAACGCTCAGCCATATCGG
CAATGGTCCGCAGATTGTATTGATCCGCCGGCGCAGGATAACCGCTGACACAGT
GCAACACGACCAACTCTTGGCAACCATTGGACTGGGCAGTAGCAATCGCTTCGG
CAATCTCTTCCGCATTGGCCATGCCGGTAGACATGATCATTGGCTTACCTGTTTG
CGCCACACGTTTTATCAATGGCAAATCTATCAACTCAAAAGACGCTATCTTGTAGG
CTGGTGCGTCAAGATCTTCCAACAAATCAACAGCAGTAAAGTCAAAAGGAGAAC
TGAAGATGGTGATCCCCAACTCTTTGGCTTTCTCAAACAACGGTTGGTGCCACT
CCCATGGCATTTGGGCCTCTTTGTAAAGTTGGTACAAATTTTTACCATCCCATAGC
CCACCGTGAATTTGAAATTCCTCACTATCACATTCAAAAGTAATAGTGTCTGCGGT
ATATGTTTGAAGTTTTATTGCATCTGCGCCCGCTTTTTTTGCCTCTTCCATGATCG
CAAAAGCACGATTGATATCACCATTGTGGTTAGCGGAGAGTTCCGCAATAATATAT
GGTGGATAGTCAGGGCCAATCTTGCGGCCATTGATGGTAATAAACGGCTTGATTA
TTTTGTCCAT 
 
neuA: 
TTACCTTAGCGTAAATAGCTTCTCAGCACGCAGCCAATCATCCTGAGTATCAATAT
CTTGCACCCTGTGGCTGGGTAATAGAACTACCTGTGTATGCACGGCAAATATAGG
TAATTTATTAAGCCAAGCATTAGCCTTTCCCCAATAAAATTGCCCCGCATCATGGTA
GGCTTCCTCCAGATCTTGGGAACGAGTTAGTTGATACTCGGGATGAAACATACTC
ACCCAACCTGACTCATCAAGCTTGATAGCGCGTTGAATCGGAAACGAAAAGCGA
GTAGCACTGAAAACAAATTGGCATTCCTTGTTGAACGTTAACAATTCTAATCCCTG
GCATAAATCATCAGGCTCAACAAAAGGTGCTGTTGCATAGAGGCAGCATACGTTT
TCCGGCACTTGCCCTTGCTGATTTATCAACCAATTAATGGCATGGCTTATCACCTC
ACCAGTAGTGGCATAATCGTTAGCAATCTCTGCCGGGCGAGTAAATGGCACTTCA
GCACCATATTCGAGTGCAACAGCAGCAATTTCAGCATCATCGGTTGAAACAATTAT
ACGTTCAAAACAACCAGCCTTCTTAGCAGCTAAGATGGACCATGCGATCATGGG
CTTGCTATGAAATGGTTTGATATTTTTCCTAGGAATACGCTTACTGCCACCACGGG
CAGGGATGATGGCAATATTCAT 
140 
 
 
flaA: 
ATGAGTCTGTATATCAATACCAACGTTTCATCGCTCAACGCTCAGCGTAACATGAT
GAACAGCACCAAATCCCTGGATACCTCCTACACCCGTCTGGCCTCCGGCCTGCG
CATCAACAGCGCCAAGGACGATGCGGCAGGTCTGCAGATTTCCAACCGTCTGA
CCTCTCAGATCAACGGTCTGGACCAGGGCAACCGCAACGCCAACGACGGCATC
TCCCTTGCTCAGACTGCTGAAGGGGCGATGGATGAAGTGACCGGTATGCTGCAA
CGCATGCGTACCCTGGCTCAACAATCCGCCAACGGTTCCAACTCCGCCAAGGAT
CGTGAAGCCCTGCAAAAAGAAGTGGATCAGCTGGGTGCCGAGATCAACCGTATC
TCCACTGCAACCACCTTTGCAGGGACCAAGCTGCTTGATGGTTCATTTAGCGGT
ACTTTCCAAGTAGGTGCTGATGCCAACCAAACAATCGGGTTTAGTTTGGCGCAAA
CAGGGGGGTTTAGTATCTCTGGGATCGCAAAAGCTGCAGGAACTACGATTGATAT
TGTGTCTGGTCCAGCAGGGAGTGTAACAACAGCGACCGGTATCTCCCTTATTTTC
ACTGGCGGCAGTGCAGGTGGGATCAGTATTAGCACTCAGAGTAAGGCCCAAGC
CGTTTTGGCTGCTGCTGATGCTATGTTGGAAGTCGTAGATAGCAAGCGAGCAGA
ACTGGGTGCGGTGCAGAACCGTCTGGATTCCACCATTCGCAACCAGGCCAATAT
CTCGGAAAACGTAAGCGCAGCCCGTTCTCGTATCCGCGATGCAGATTTTGCAAC
CGAGACCGCCAATATGACCAAGCAGAATATCCTGCAACAGGCCGCTTCCAGCAT
CCTGGCCCAGGCCAATCAGCGTCCGCAGTCTGCGCTCTCCCTGCTGCAGAACT
AA 
 
 
 
 
 
 
